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Abstract
The obligate intracellular pathogens Plasmodium falciparum and Toxoplasma gondii remodel their host cell to
facilitate their intracellular development and progress through their asexual life cycle, a virulent lytic cycle
responsible for parasite-mediated pathogenesis. While several studies have highlighted parasite proteins that
interact with the host cell during this cycle, host proteins exploited by the parasite for successful growth and
conversely, host molecules evolutionarily tuned to control parasite infection remain unclear. We addressed
this question from both sides of the host-parasite interaction in the hope to leverage biological discovery of
host molecules involved in infection into the validation of novel drug target candidates with vastly reduced
potential for resistance: (1) building on previously established roles of host calpain during the lytic cycle to
elucidate host pathways that facilitate parasite life cycle progression and (2) clarifying the existing role of
platelets in innate control of parasitic disease. Comparative proteomics, genetics, and biochemical techniques
led us to the discovery of a complex Gaq-coupled, protein kinase C (PKC)-mediated host signaling cascade
common to both T. gondii and P. falciparum that results in cytoskeletal compromise and facilitates host
calpain activation immediately prior to parasite release (Millholland et al., 2011; Millholland et al., 2013). The
complexity of this pathway represented an untapped resource of antimalarial targets; indeed, inhibitors of key
host signaling components demonstrated antiparasitic activity in murine models of malaria and
toxoplasmosis. Conversely, host platelets were previously shown to have antimalarial capacity, leading us to
characterize this host-parasite interaction in the hope to harness this antimalarial activity to optimize
therapeutic potential. Upon screening molecules secreted in the blood stream, we identified Platelet Factor 4
as the host defense peptide (HDP) component of platelets capable of killing malaria parasites via selective
lysis of the parasite digestive vacuole (DV), the site of hemoglobin digestion(Love et al., 2012). To exploit this
DV lysis mechanism in a drug discovery effort, we tested a library of small, nonpeptidic mimics of HDPs and
identified compounds that potently killed P. falciparum in vitro and reduced parasitemia in a murine malaria
model. Taken together, these data reinforce the feasibility of targeting host molecules as a novel antiparasitic
strategy.
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ABSTRACT 
 
HOST-APICOMPLEXAN PARASITE INTERACTIONS:  
LEVERAGING BIOLOGICAL DISCOVERY INTO ANTIPARASITIC DRUG DEVELOPMENT 
Melanie G. Millholland 
Doron C. Greenbaum 
 
The obligate intracellular pathogens Plasmodium falciparum and Toxoplasma gondii 
remodel their host cell to facilitate their intracellular development and progress through 
their asexual life cycle, a virulent lytic cycle responsible for parasite-mediated 
pathogenesis. While several studies have highlighted parasite proteins that interact with 
the host cell during this cycle, host proteins exploited by the parasite for successful 
growth and conversely, host molecules evolutionarily tuned to control parasite infection 
remain unclear. We addressed this question from both sides of the host-parasite 
interaction in the hope to leverage biological discovery of host molecules involved in 
infection into the validation of novel drug target candidates with vastly reduced potential 
for resistance: (1) building on previously established roles of host calpain during the lytic 
cycle to elucidate host pathways that facilitate parasite life cycle progression and (2) 
clarifying the existing role of platelets in innate control of parasitic disease.  Comparative 
proteomics, genetics, and biochemical techniques led us to the discovery of a complex 
Gaq-coupled, protein kinase C (PKC)-mediated host signaling cascade common to both 
T. gondii and P. falciparum that results in cytoskeletal compromise and facilitates host 
calpain activation immediately prior to parasite release (Millholland et al., 2011; 
Millholland et al., 2013). The complexity of this pathway represented an untapped 
resource of antimalarial targets; indeed, inhibitors of key host signaling components 
demonstrated antiparasitic activity in murine models of malaria and toxoplasmosis. 
Conversely, host platelets were previously shown to have antimalarial capacity, leading 
us to characterize this host-parasite interaction in the hope to harness this antimalarial 
activity to optimize therapeutic potential. Upon screening molecules secreted in the 
blood stream, we identified Platelet Factor 4 as the host defense peptide (HDP) 
component of platelets capable of killing malaria parasites via selective lysis of the 
parasite digestive vacuole (DV), the site of hemoglobin digestion(Love et al., 2012). To 
exploit this DV lysis mechanism in a drug discovery effort, we tested a library of small, 
nonpeptidic mimics of HDPs and identified compounds that potently killed P. falciparum 
in vitro and reduced parasitemia in a murine malaria model. Taken together, these data 
reinforce the feasibility of targeting host molecules as a novel antiparasitic strategy. 
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INTRODUCTION 
Apicomplexan Parasite Biology 
	  
Intracellular parasites of the phylum Apicomplexa cause significant morbidity and 
mortality worldwide. Toxoplasma gondii is a highly successful protozoan parasite, 
chronically infecting an estimated 30% of the world’s population (Weiss and Dubey, 
2009). Including many water-borne protozoa that can threaten human health via 
accidental or intentional contamination of public water supplies, such as the class B 
biodefense agents Toxoplasma gondii, Cryptosporidium hominis, and Cryptosporidium 
parvum, this phylum is also a home to the malaria parasite Plasmodium falciparum, 
which continues to be a devastating disease and a global health burden responsible for 
>500 million clinical cases of malaria that result in >1 million deaths each year (Gething 
et al., 2011). No completely satisfactory therapies exist for treating infection by these 
parasites: hypersensitivity to sulfonamides and lincosamides limits their utility against T. 
gondii, particularly in immunocompromised patients, and there is no effective chemo-
therapy for acute cryptosporidiosis. While vector control may reduce malaria parasite 
prevalence, chemotherapy remains the principal means of controlling disease. 
Unfortunately, the emergence and spread of drug-resistant P. falciparum, the parasite 
that causes the most deaths, has rendered most of the traditional antimalarials (e.g. 
chloroquine) clinically ineffective, necessitating the discovery of novel antimalarials. 
Ideally, novel treatments will minimize resistance, though most approaches to develop 
therapeutics generate resistant parasites in the lab and field.  
Most Apicomplexan parasites are obligate intracellular pathogens that traverse a 
complex life cycle, including both sexual and asexual stages. The chronic asexual phase 
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includes a virulent lytic cycle responsible for parasite-mediated pathogenesis. During this 
lytic cycle, parasites (Plasmodium merozoites, T. gondii tachyzoites) divide inside a 
parasite-modified vacuole following host cell invasion (the parasitophorous vacuole or 
PV). To do this they must dramatically remodel their host cell to facilitate invasion, 
intracellular development, avoid host defenses, and finally to exit from their host cell to 
renew the lytic cycle.  Recently, there have been several studies investigating parasite 
proteins that interact with host proteins during the lytic cycle, but there is far less known 
about host proteins necessary for parasite growth.  
Host-Pathogen Interactions Necessary for Survival: Getting In and Getting Out 
The asexual phase of the intracellular cycle is comprised of a lytic cycle in which 
parasites invade a host cell and then establish an intracellular niche within a particular 
host cell type (Toxoplasma gondii infects any nucleated animal cell, Cryptosporidium 
parvum specifically infects enterocytes while Plasmodium falciparum infects 
erythrocytes). To initiate the intracellular cycle, parasites first attach to the host cell via 
low affinity interaction and actively reorient so that the end with apical organelles is 
pointed inwards towards the host cell. Parasite ligand interactions with host receptors 
cause irreversible attachment, which engages the parasite actin/myosin motor system to 
pull the host membrane around the parasite. Completion of invasion involves the sealing 
of the membrane to create a PV within which the parasite divides and completes its 
entire intracellular cycle. After replication is complete, the daughter parasites must exit 
from this PV and also the host cell in order to invade uninfected cells and continue the 
infection anew (Glushakova et al., 2005; Salmon et al., 2001). Many parasite-derived 
proteins, including proteases (Brossier et al., 2005; Buguliskis et al., 2010; Starnes et al., 
2009), kinases (Carruthers et al., 1999; Straub et al., 2011; Sugi et al., 2010) and 
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surface ligands (Brossier et al., 2003; Carruthers et al., 1999; Carruthers et al., 2000) 
have been implicated as necessary for invasion.  Knockdown or inhibition of many of 
these proteins has been shown to prevent parasite invasion and cause parasite death. 
Though parasite proteins required for invasion have been studied in detail, very little is 
understood on the host side, aside from a recent finding that invasion of T. gondii 
tachyzoites is dependent on host actin polymerization (Gonzalez et al., 2009), as 
mediated by interaction with a parasite-derived secreted actin-binding protein (toxofilin), 
which facilitates host cell actin filament disassembly and turnover (Delorme-Walker et 
al., 2012). Thus, invasion has proven to be a critical phase for therapeutic intervention, 
as parasites unable to invade are not only unable to replicate, these stranded parasites 
have been shown to die within hours of failed invasion (Buguliskis et al., 2010; Larson et 
al., 2009; Lovett and Sibley, 2003; Poupel and Tardieux, 1999; Sibley and Andrews, 
2000; Teo et al., 2007). 
Once a parasite successfully invades a host cell, it initiates major changes in its new 
environment.  This is best illustrated by the extreme alterations P. falciparum parasites 
make to their new, and transient, home in a host erythrocyte. P. falciparum infection 
reduces deformability (Maier et al., 2008) and changes the adhesive properties of the 
host erythrocyte, due to the appearance of knob-like protrusions on the surface (Crabb 
et al., 1997; Sherman et al., 1992; Smith et al., 1992) and specialized secretion of 
parasite proteins into the host cell (Hiller et al., 2004; Marti et al., 2005). Yet perhaps the 
most profound change to the erythrocyte is its complete collapse at the end of the 
parasite erythrocytic cycle, as the newly replicated merozoites are released (Glushakova 
et al., 2005). For many years, parasite proteases have been thought to be important for 
rupture of malaria parasites from host cells (Hadley et al., 1983): from initial inhibitor-
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based data, a two-step model of parasite rupture was proposed, requiring the activity of 
a cysteine and possibly a serine protease, as the general cysteine protease inhibitor E64 
and the cysteine/serine protease inhibitors leupeptin and chymostatin inhibited PV and 
erythrocyte plasma membrane rupture, respectively (Glushakova et al., 2009; Salmon et 
al., 2001; Wickham et al., 2003a). More recently, several reports have implicated the 
involvement of three proteases in the rupture process: the parasite-derived proteases 
PfDPAP3 (Arastu-Kapur et al., 2008) and PfSub1 (Yeoh et al., 2007), and the human 
protease calpain-1 (Chandramohanadas et al., 2009). In addition to proteolytic enzymes, 
it has also been established that osmotic forces (Glushakova et al., 2010), changes in 
parasite calcium flux (Nagamune et al., 2008),  pore-forming proteins (Kafsack et al., 
2009),  and a kinase (Dvorin et al., 2010) are important for efficient egress of 
apicomplexan family parasites.  
Although these studies have provided details on a variety of parasite proteins that act 
or are proteolytically processed during egress (Bowyer et al., 2010), we hypothesized 
that the parasite likely modifies host erythrocyte proteins and specifically needs to 
destabilize the host cytoskeletal-membrane network to efficiently exit from the host cell,. 
Thus, we were interested in a more comprehensive understanding of changes to the 
infected erythrocyte membrane and cytoskeleton proteomes as the parasites prepare 
the host cell for rupture and merozoite exit. 
Egress of both P. falciparum (Wickham et al., 2003a) and the related apicomplexan, 
T. gondii (Black et al., 2000; Lavine et al., 2007), has been shown to be a Ca2+-
dependent process, inducing secretion of parasite-derived pore-forming proteins and 
activation of host-derived proteases. Ca2+ dynamics during egress have been best 
described within T. gondii: (i) It is well established that T. gondii egress can be induced 
via treatment with the calcium ionophore A23187 (Endo et al., 1982). (ii) T. gondii egress 
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has been shown to be controlled by a plant-like pathway for cyclic adenosine 
diphosphate ribose (cADPR) production through accumulation of abscisic acid, which 
results in elevated Ca2+ levels that stimulate egress (Chini et al., 2005; Nagamune et al., 
2008), and (iii) Ca2+-induced micronemal secretion of TgPLP-1, a perforin-like protein, 
has been shown to aid in lysis of the PV membrane during T. gondii egress (Kafsack et 
al., 2009). We have recently discovered that apicomplexan parasites co-opt the Ca2+-
regulated host cysteine protease calpain to allow for egress from the host cell 
(Chandramohanadas et al., 2009). In both P. falciparum and T. gondii, calpain was 
shown to be necessary for egress, as it is specifically activated just prior to parasite 
egress and is involved in the cleavage of several cytoskeletal proteins including α/β-
spectrin and ankyrin. Pharmacological inhibition or depletion of calpain from host 
erythrocytes led to a robust block in parasite egress, thus limiting life cycle progression. 
Recent work on T. gondii has implicated a perforin-like protein (TgPLP-1) as critical for 
egress (Kafsack et al., 2009). TgPLP-1 is a pore-forming protein similar to that used by 
cytotoxic T lymphocytes (CTL) for target cell killing (Voskoboinik et al., 2006).  Perforin 
secretion by CTLs is thought to allow Ca2+ and granzyme entry, leading to target cell 
death (Chowdhury and Lieberman, 2008), which may link this parasite protein to host 
Ca2+ signaling, as Ca2+ within the parasite may traverse this pore and mobilize into the 
host cell to activate a Ca2+ signaling pathway. TgPLP-1 KO parasites are crippled in 
vitro, and unable to establish infection in a mouse model, indicating the importance of 
this protein and the process of egress in the parasite survival. Deposition of this protein 
is necessary for efficient egress from host cells, as TgPLP-1 KO parasites fail to egress 
normally from the PV and host cell membranes. Strikingly, co-infection of host cells with 
both WT parasites and TgPLP-1 KO parasites abrogates the egress defect in the KO 
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parasite, thus implicating the likelihood of a parasite-induced freely diffusible second 
messenger in the host cell, which activates a common host-derived egress pathway 
allowing both parasites to exit.   
Platelets, Malaria, and Host Defense Peptides (HDPs): the Other Side of the Coin.  
In addition to interactions with the host that facilitate parasite survival, hosts have 
developed numerous defenses against these invading pathogens that have spanned 
evolutionary time, efficiently overcoming the barrage of potential invaders. Recent work 
has shown that platelets can bind infected erythrocytes and kill the intracellular malaria 
parasite (McMorran et al., 2009). Platelets have been long known to interact 
cooperatively with erythrocytes in thrombogenesis, both generally and in the specific 
case of sickle cell disease (Rocca and FitzGerald, 1997), though previous studies have 
suggested that thrombocytopenia is a poor prognostic marker in malaria (Moerman et 
al., 2003) and significantly associated with cerebral malaria (Cox and McConkey, 2010; 
Wassmer et al., 2008).  
Based on the knowledge surrounding possible interactions between platelets and P. 
falciparum and prior data that platelets contain HDP-like proteins (Tang et al., 2002), we 
hypothesized that perhaps innate immune proteins such as HDP-containing proteins that 
are found in either platelets could be natural antiparasitics and were likely optimized 
against these pathogens following years of concomitant evolution. Antiparasitic activities 
have been reported for a number of HDPs and are thought to kill protozoa, though the 
physiological significance of the reported interactions is questionable (Mangoni et al., 
2005; Vizioli and Salzet, 2002). The HDPs that have previously been studied, 
dermaseptins, are not present in blood or cells that circulate in the blood and kill intra-
erythrocytic parasites by disrupting the erythrocyte plasma membrane of infected 
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erythrocytes rather than directly killing parasites (Feder et al., 2000; Krugliak et al., 
2000).  
 HDPs play a central role in the innate immune system (Finlay and Hancock, 
2004; Hancock and Lehrer, 1998; Tossi et al., 2000; Zasloff, 2002). There are two types 
of HDPs comprising ribosomally and nonribosomally synthesized peptides. Over 700 
HDPs have been identified, varying in length (12 - 80 residues), sequence, and three-
dimensional structure. The two major classes of HDPs are α-helical (magainin and 
cecropin) and disulfide-rich β-sheets (bactenecin and defensin), although other tertiary 
structures also exist. HDPs are particularly important in insects and plants, which lack an 
adaptive immune response based on T-cells and antibodies. Further, HDPs display very 
broad-spectrum action against bacteria, fungi, protozoa, and even viruses, which has 
promoted their use as new leads for developing antibiotics (Zasloff, 2002). 
 HDPs share common features including highly amphiphilic topologies in which 
the hydrophilic and hydrophobic side chains segregate onto distinctly opposing regions 
or faces of the overall folded conformation. Numerous studies with linear and cyclic 
peptides have strongly supported the hypothesis that the physicochemical properties of 
HDPs, rather than any specific sequence or structure, are responsible for their activities. 
It is generally believed that this amphiphilic topology is essential for insertion into and 
disruption of the cytoplasmic membrane leading to patogen death (Zasloff, 2002). 
However, it is important to remember that while these compounds primarily target 
membranes, specific HDPs can interact with other components of the innate immune 
system (reviewed in (Finlay and Hancock, 2004)) and many HDPs appear to act on 
additional protein and nucleic acid targets (del Castillo et al., 2001; Kragol et al., 2001; 
Park et al., 1998). 
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 The cytotoxic activity and basis of specificity of cationic and amphiphilic peptides 
has been best studied in bacteria. This specificity for bacteria over mammalian cells is 
most likely related to fundamental differences between the two membrane types: 
bacteria have a large proportion of negatively charged phospholipid headgroups on their 
surface while the outer leaflet of animal cells is composed mainly of neutral lipids 
(Zasloff, 2002).  Also, the presence of cholesterol in the animal cell membrane appears 
to reduce the HDP activity. The bactericidal activity of these peptides is very rapid, 
occurring within minutes after exposure of bacteria to lethal doses of peptide.  Several 
mechanisms have been proposed for the process of cell killing (Christensen et al., 1988; 
Ludtke et al., 1995; Matsuzaki et al., 1995, 1996; Pouny et al., 1992). It appears that 
HDPs bind to the membrane surface in a non-cooperative fashion and then aggregate 
once a threshold concentration is reached causing membrane permeabilization. 
Membrane permeabilization is associated with a variety of other events including 
membrane depolarization, leakage of cellular metabolites, loss of compositional integrity 
due to enhanced membrane flip-flopping and translocation of peptides to the cytoplasm 
where additional targets, such as RNA, DNA, and various enzymes, can be encountered 
(Scott et al., 2008). It is unclear which of these events are primarily responsible for 
bacterial killing and multiple hit models have been proposed with the exact mechanism 
being dependent on the peptide and bacterium in question (Patrzykat et al., 2002). 
Nevertheless, HDPs have remained an effective weapon against bacterial infection over 
evolutionary time indicating that their mechanism of action thwarts bacterial responses, 
which normally lead to resistance against toxic substances. This premise is supported by 
data showing that no appreciable resistance to the action of the HDPs occurs after 
multiple serial passages of bacteria in the presence of sub-lethal concentrations of the 
peptides (Ge et al., 1999; Mosca et al., 2000; Tew et al., 2002). 
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 Mature Platelet Factor 4/CXCL4, a member of the CXC chemokine family, is a 70 
amino acid protein with an N-terminal cytokine domain, a central domain responsible for 
tetramerization, and a C-terminal domain that binds heparin and also can act as an HDP 
(Yeaman et al., 2007). PF4 was the first characterized chemokine (Brandt et al., 2000), 
though unlike other chemokines, PF4 does not have strong chemotactic properties and 
does not interact with common chemokine receptors except human CXCR3B, an 
alternatively-spliced CXCR3 (Lasagni et al., 2003). PF4 is a cationic tetrameric molecule 
with high affinity for heparin and other large, negatively-charged molecules (Loscalzo et 
al., 1985). Upon platelet activation, PF4 is released from platelet alpha-granules in high 
local concentrations, up to 100 µM proximal to a clot (Lambert et al., 2007b). It is 
important to note that PF4 has been implicated in both inflammation (Scheuerer et al., 
2000; Srivastava et al., 2008) and thrombosis (Eslin et al., 2004b). The Poncz lab has 
shown that PF4 released from activated platelets forms complexes with endogenous 
GAGs on the surface of platelets (Rauova et al., 2006) and monocytes (Rauova et al., 
2006) and likely on other hematopoietic and vascular cells. Mice that are knockout for 
the cxcl4 gene (Eslin et al., 2004b) (deficient in PF4 (PF4 KO)) or overexpress hPF4 
(hPF4+) have proven to be important tools in understanding in vivo PF4 biology during 
thrombosis and megakaryopoiesis (Koenen et al., 2009; Lambert et al., 2007a).  
 Recently, Srivastava et al. have shown that PF4 mediates increased 
inflammation in a mouse model of experimental cerebral malaria (Srivastava et al., 
2008), which they posit may occur through the chemokine domain of PF4. It is unclear if 
these observations are clinically relevant to cerebral malaria in humans, given that this 
murine model (P. berghei ANKA) is complicated by severe inflammation in the brain and 
CNS, unlike human cerebral malaria in which little, if any, inflammation is seen 
(Bruzzone et al., 2009; Haldar et al., 2007; White et al., 2009). As human cerebral 
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malaria is a consequence of intravascular sequestration of infected erythrocytes in the 
brain vessels and capillaries, rather than increased inflammation, it is unlikely that PF4 
mediates increased inflammation during this disease process. Murine models of cerebral 
malaria are further complicated by the marked accumulation of leukocytes and platelets 
in the brain venules and capillaries, a phenomenon not seen in human pathology (White 
et al., 2009). Given our preliminary in vitro and in vivo data implicating PF4 in 
Plasmodium killing, utilizing P. falciparum in culture and a murine model that mimics 
systemic anemia during severe infections (P. yoelli), we hypothesize that in fact the HDP 
domain of PF4 serves as a natural human antimalarial and may offer insight into 
development of novel therapeutics with little propensity for generation of resistance. 
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II. MATERIALS AND METHODS 
 
Reagents. Monoclonal antibodies against calpain-1 and Band 3 were purchased from Sigma. 
Spectrin antibodies (α, β and β C-terminal domain) were donated by Dr. David Speicher (Wistar 
Institute, Philadelphia), Band 4.9 antibody was purchased from BD Biosciences and all the other 
antibodies (α-Adducin, Ankyrin-1, Flotillin-1, Stomatin, Actin, and CD47) were purchased from 
Santa Cruz Biotechnology. Calpastatin was purchased from EMD Biosciences. Recombinant 
human calpain-1 was purchased from Calbiochem. DCG04 was synthesized as reported 
previously (Greenbaum et al 2000). Streptavidin-HRP was purchased from Vector Labs, and 
Fura-2-Dextran and SYTOX Green from Invitrogen. Purified human calpain-1 was purchased 
from Sigma, and calpastatin domain I from EMD Chemicals. Commercially available antibodies 
were obtained from the following sources: anti-OXGR1, anti-GPR91, and anti-TRPC6 from 
Abcam; anti-ankyrin-1, anti-GAPDH, anti-calmodulin 1, anti-calmodulin 2, anti-CAMKI, anti-
CAMKII, anti-PKAcat, anti-PLCb, anti-PLCg from Santa Cruz; anti-PKCa and anti-PKCb from Cell 
Signaling. Anti-α- and β-spectrin antibodies were kindly provided by D. Speicher (Wistar Institute, 
USA).  
 
Growth and maintenance of P. falciparum cultures. Strain 3D7 Plasmodium parasites were 
cultured in human erythrocytes (4% hematocrit) under standard conditions (37°C, 
5%O2/5%CO2/90%N2) in RPMI buffer supplemented with HEPES and hypoxanthine. Replication 
was tightly synchronized via serial treatments with D-sorbitol to lyse trophozoite- and schizont-
infected erythrocytes. The remaining ring-stage parasites were cultivated to yield schizonts (~42 
hr post-infection), which were selectively purified using a Miltenyi Biotec magnetic separator. 
Cultures were staged by microscopy of Giemsa-stained blood smears and flow cytometry using 
SYTOX Green (Life Technologies) as a marker of DNA content. Cultures were fixed with 4% 
paraformaldehyde/0.0016% gluteraldehyde for 1 hour and permeabilized with 0.1% Triton X-100 
for 10 minutes at room temperature prior to incubation with 5 µM SYTOX Green for 10 minutes 
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and analysis on an Accuri Flow Cytometer. 
 
Growth and maintenance of T. gondii cultures. RH strain T. gondii tachyzoites, and parasite 
lines constitutively expressing P30-GFP or P30-RFP were cultivated in confluent monolayers of 
human foreskin fibroblasts, human U2OS cells, or human A549 cells. Cells were grown to 
confluence in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum and 
replaced upon infection with minimal essential medium containing 10% dialyzed fetal bovine 
serum. 
 
Preparation of erythrocyte membrane/cytoskeletal fractions. To prepare the infected 
erythrocyte membrane, schizont-stage infected erythrocytes (∼35-40 hpi) were purified using a 
magnetic column (Miltenyi Biotec). The parasites were then treated with 0.02% saponin in PBS 
for 10 min at 4°C and centrifuged at 1,500xg. The supernatant was centrifuged again at 4,000xg. 
This supernatant containing infected erythrocyte and parasitophorous vacuole (PV) contents was 
then ultracentrifuged (200,000xg for 2 hour at 4°C) to collect membranes. The 
membrane/cytoskeletal pellet was washed three times with PBS and subjected to a delipidation 
procedure by ethanol extraction (Pasini et al., 2006) for 90 min prior to freezing with protease 
inhibitors (Roche) at -800C. Finally, uninfected erythrocyte membranes were prepared as 
mentioned previously (Pasini et al., 2006). Erythrocytes were washed twice with phosphate 
buffered saline (PBS) and subjected to hypotonic lysis in 5 mM lysis buffer (5 mM K2HPO4, pH 
8.0) containing protease inhibitors for 10 min in ice. Ghost membranes were collected by 
centrifugation of the lysate (200,000xg for 2 hour at 4°C). The pellet fraction containing the 
erythrocyte membrane was washed until pellet appeared as yellow/white ghosts. After 
delipidation, the membrane samples were frozen until used. 
Purification and microscopic analysis of the erythrocyte-derived vesicles formed during 
rupture. Schizont-stage parasites ~40 hours post invasion (hpi) were purified from synchronous 
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cultures using a SuperMacs magnet (Miltenyi Biotech) and resuspended in culture medium. Once 
the majority of schizonts ruptured, as determined by Giemsa smears, the culture media was 
treated with protease inhibitor cocktail and further collected by centrifugation at 1,500xg for 10 
min to remove residual uninfected and infected erythrocytes. This was followed by centrifugation 
at 5000xg for 30 min to remove extracellular merozoites. Erythrocyte membrane material, 
including small vesicles and loose membranes, resulting from rupture of parasites from 
erythrocytes was then purified from the residual media by ultracentrifugation (L8-70M 
ultracentrifuge, Beckmann) at 200,000xg for 2 hour at 4°C. The resulting erythrocyte membrane 
material was then washed three times with PBS. The post-rupture erythrocyte vesicles isolated 
were stained with FM4-64 (Invitrogen) and DAPI for DNA. Samples were analyzed using a 
fluorescent microscope (Carl Zeiss Axioskop). Composite images were produced using 
Photoshop 6.0.1. 
Protein separation for mass spectrometry (MS). Aliquots from uninfected, infected 
erythrocytes and post-ruptured vesicle membranes (∼100 µg from each sample) were solubilized 
in Laemmli buffer under reducing conditions. After resolving on a 4-16% pre-cast gradient gel 
(BioRad), polypeptides were stained with colloidal Coomassie. For mass spectrometric purposes, 
gel slices of 0.5 cm were excised from the entire length of the gel for each sample (total of 34 
slices). Gel slices were de-stained with 20 mM ammonium bicarbonate and dried in 100 % 
acetonitrile. Tryptic peptides from each gel slice were dried on a vacuum evaporator for mass 
spectrometry.  
Mass Spectrometry. These studies were completed by Angela Wehr, Ph.D. Tryptic peptides 
were resuspended in acetonitrile/water. Peptides were separated by reverse phase using an 
Agilent 300 Extend-C18 column (3.5mm, 2.1 x 150mm).  After a 6 min isocratic hold at 100% 
mobile phase A linear gradient was run over the next 33 minutes increasing the percent B (0.1% 
formic acid, 95% acetonitrile) to 60% all at a flow rate of 150 mL/min. Peptides were eluted online 
to a ThermoFinnigan LTQ mass spectrometer (ThermoFisher, San Jose, CA) and were ionized 
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using ESI in the positive mode. Nitrogen was used as the sheath gas and collision induced 
disassociation (CID) experiments employed helium. Data dependent scanning was used to 
identify the top five most abundant ions over the range m/z 400-1500.  Each of the five most 
abundant ions was then subjected to product ion scanning. (A mass tolerance of 2.0 Da for 
precursor ions and 1.0 Da for fragment ions was permitted). We used the extract_msn.exe tool 
from BioWorks version 2.x for generating peak lists from individual spectra. 
Processing of Mass Spectrometry Data. These studies were completed by Angel Pizzarro, 
Ph.D. at the Institute for Translational Medicine and Therapeutics at the University of 
Pennsylvania. The raw MS/MS data were searched through SEQUEST (TurboSEQUEST - PVM 
Slave v.27 (rev. 12), (c) 1998-2005) (Thermo Electron, San Jose, CA) against either a human 
RefSeq database (NCBI version updated 11/19/07) or the Plasmodium database (plasmodb.org). 
The databases were indexed using strict trypsin cleavage rules (K and R) with two maximum 
internal cleavage sites. Carbamidomethylation of cysteine residues (fixed modification) and 
oxidation of methionine (variable modification) were pre-set for the database searches.  The 
SEQUEST output files were analyzed and validated by PeptideProphet (Version 3.0) as an 
automated method to assign peptides to MS/MS spectra.  Post-analysis of the data was 
performed using the Trans Proteomic Pipeline (TPP) with a peptide identification probability cutoff 
of 0.05, which for all data sets corresponded to a FDR < 3%, and was  < 2% for most data sets. 
Data was further filtered and proteins with at least three peptides identified by SEQUEST were 
considered as positive ‘hits’. Multiple biological experiments were carried out to reproduce and 
confirm the proteomic results. GeneSpring Version 11.5 (Agilent) was used for generating heat 
map from the information obtained from MS analysis to analyze the relative distribution of 
proteins in gel slices among the three proteomes. 
Immunodepletion and loading of erythrocytes. Erythrocyte ghosts were prepared by hypotonic 
lysis as previously described utilizing 5 mM K2HPO4 at <4°C for 15 minutes (Chandramohanadas, 
et al 2009). To immunodeplete target proteins, target antibodies were pre-conjugated to Protein 
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G-Sepharose (Upstate/Millipore) following a titration to achieve maximal immunodepletion (1-10 
µg antibody per 106 erythrocytes). Conjugates were incubated with ghosts for 3 hours on ice with 
gentle mixing and repeated with fresh antibody-sepharose conjugates up to 3 times. The slurry 
was separated by centrifugation and followed by another round of immunodepletion for cells 
immunodepleted of multiple proteins. Ghosts were resealed by gradual addition of 5X resealing 
buffer (475 mM KOAc, 25 mM Na2HPO4, 25 mM MgCl2, 237.5 mM KCl, pH 7.5) over 1 hr at 
37°C. Parallel studies were carried out using anti-PKAcat, and mock treated erythrocytes were 
incubated with Sepharose G beads without antibodies. 
 
Analysis of host protein function during parasite exit from immunodepleted erythrocytes. 
Resealed erythrocytes were prepared as described above. Schizont stages were isolated from 50 
ml parasite culture by magnet purification ~40 hr after sorbitol synchronization, and added to 
mock-treated, PKCa/b-depleted, PLCb1-depleted, calmodulin-1-depleted, Gaq-depleted, or 
calpain-1-depleted erythrocytes to a final hematocrit of 4%. Parasite progress through the 
intraerythrocytic cycle was monitored by Giemsa smear. Schizont-stage parasites were followed 
to assess egress and the establishment of rings in newly-infected erythrocytes from 45-60 hpi. 
Flow cytometry was used for quantitative evaluation of P. falciparum development. 106 events 
were collected per sample using an Accuri flow cytometer and analyzed using Accuri software, 
gating to exclude debris defined by scatter characteristics, and uninfected erythrocytes based on 
low fluorescence; rings and trophozoites were distinguished from schizonts based on DNA 
content. Data are presented as mean ± SEM; n=4. 
 
Mechanical removal of P. falciparum from erythrocytes. Needle-shearing experiments were 
completed as previously described (Dvorin, et al 2010) with modifications. Parasites trapped 
within erythrocytes immunodepleted of calpain-1, PKCa/PKCb, PLCb1, or CaM-1, or negative 
control Mock-immunodepleted or PKAa/bcat-immunodepleted erythrocytes, were plated in 
quadruplicate. At the indicated timepoint, cultures were sheared by 20 strokes through a 28.5 
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gauge needle. Cultures were incubated for an additional 12 h and ring stage parasitemia 
determined by Giemsa smear microscopy and flow cytometry of DNA content. Data are 
presented as mean ± SEM; n=4. 
Monitoring calpain activation and membrane binding. Immunodepleted cells were prepared 
as above and challenged with synchronous, magnet-purified schizont stage parasites. Following 
48-hour incubation, infected cells were incubated with DCG04 (5 µM) and membrane fractions 
were prepared from each sample by ultracentrifugation (2 h at 200,000xg). Equal amounts of 
solubilized protein from each sample was separated by SDS-PAGE, transferred to PVDF 
membrane, and probed for biotin using streptavidin-HRP, revealing DCG04 labeling of active 
calpain. As a loading control, the same western blots were probed with actin antibodies (Santa 
Cruz). 
 
Erythrocyte membrane proteolysis in vitro by calpain-1. Aliquots of 10 µl (1µg/ µl) erythrocyte 
membrane preparations were treated with 100 ng of purified calpain-1 in reaction buffer (20 mM 
HEPES, 10 mM DTT & 5 mM CaCl2) for 30 min at 37°C. Negative controls were included by pre-
incubating erythrocyte membranes with calpastatin or EGTA prior to the addition of activated 
calpain. Samples were solubilized in Laemmli buffer under reducing conditions and resolved via 
SDS-PAGE and visualized by colloidal Coomassie. A fraction from each reaction was also 
resolved on SDS-PAGE, transferred to PVDF membrane and probed for α- and β-Spectrins, 
Ankyrin-1, Stomatin, and Flotillin using commercially available antibodies. 
Western Blot Analyses. Protein samples were solubilized in Laemmli buffer, separated by SDS-
PAGE and transferred to PVDF membranes. Membranes were probed using available antibodies 
and visualized with corresponding secondary antibodies conjugated to HRP (Pierce).  Hypotonic 
lysis and resealing of erythrocytes with calpastatin was done as previously published [15]. 
Proteomic Protein Profiling. These studies were completed in collaboration with Rajesh 
Chandramohanadas, Ph.D. Protein degradation was assessed by creating “chromatograms” 
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where the number of peptides identified for each protein was plotted against the corresponding 
gel slice where it was identified (as an approximation of molecular weight) from uninfected, 
infected and post-rupture erythrocyte membrane proteomes. Majority of proteins peaked in gel 
slices that roughly corresponded to the nominal molecular weight among the three proteomes. 
Appearance of “peptide peaks” in lower molecular weight areas of the gel in the post-rupture 
proteome and a corresponding absence or lessening of this peak in both uninfected and infected 
samples suggested protein degradation in the former sample. To further evaluate protein 
processing, peptides identified from proteolytic fragments were aligned manually against peptides 
identified from the full-length protein (identified at the correct molecular weight area of the gel), for 
several proteins that were found processed using chromatograms.  
Immunofluorescence studies. Synchronous P. falciparum-infected erythrocytes or P30-
GFP/P30-RFP T. gondii-infected U2OS cells were fixed for 1 hour at RT with 4% 
paraformaldehyde/0.008% gluteraldehyde, washed three times with PBS, permeabilized using 
0.1% Triton X-100 for 10 minutes at 37°C, and blocked using 5% milk in PBS for 1 hour at RT. 
Cells were incubated with primary antibodies to adducin-1 (Santa Cruz) in 5% milk in PBS 
overnight at 4°C, washed three times with PBS, and incubated with secondary antibodies 
preconjugated to Alexa-568, Alexa-Cy3, or Alexa-488 (Life Technologies) for two hours at RT. 
Cells were washed three times prior to incubation with Hoechst DNA stain and imaging on a 
Leica DMI6000B epifluorescent scope. 
 
Monitoring T. gondii tachyzoite invasive capacity following block in host cell cytolysis. 
Utilizing a T. gondii RH parasite line that expresses firefly luciferase, infected cells were 
mechanically disrupted via scraping and filtration to remove host cell material at specified time 
points following tachyzoite arrest within A549 host cells (beginning at 40 hpi) expressing 
S716A/S726A mutant adducin.  Parasites were then allowed to invade confluent monolayers of 
HFF cells in 96-well plate format and assessed for viability 12 hours later utilizing the Luciferase 
Reporter Assay Kit (Biovision) according to manufacturer’s instructions.   Parasite viability was 
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assessed relative to that of tachyzoites that originally infected wild-type A549 cells prior to 
mechanical release. Data shown are means of at least 3 separate experiments +/- SEM. 
 
siRNA Screen and shRNA stable knockdown generation. Primary siRNA oligos were 
purchased from Santa Cruz, oligos for follow up screens were purchased from Ambion. siRNAs 
were added at a final concentration of 20 nM in 96-well plates and titrated to achieve maximal 
knockdown by 72 hours post-transfection, along with 106 U2OS cells in culture medium lacking 
phenol red. Reverse transfection was carried out using Lipofectamine 2000 (Invitrogen) according 
to the manufacturer’s instructions. Transfected host cells were inoculated with 105 P30-GFP-
expressing T. gondii tachyzoites 24 hr post-transfection, and followed throughout the intracellular 
cycle to assess invasion, replication, and egress rates at 6, 24, 44, and 60 hpi. Data are 
presented in Figure 1B and C as mean number of unruptured vacuoles at 60 hpi versus 44 hpi ± 
SEM; n=4. siRNA knockdown was confirmed via western blot of mirrored cultures utilizing 
validated antibodies from Santa Cruz. Stable knockdown cell lines were generated following 
transfection with huSH shRNA plasmids (Origene) encoding target shRNAs conjugated to soluble 
cytoplasmic RFP to affirm knockdown and selection with puromycin (1 µg/ml) for 2 passages, 
prior to isolation of clonal populations. Double knockdown cells were generated utilizing pGFP-B-
RS expression vectors (Origene) and selection with blasticidin. Following confirmation of 
knockdown via western blot, cells were cultured in the absence of selection pressure. 
 
T. gondii invasion, replication, and egress in knockdown cultures. Intracellular parasite 
growth was measured by counting the number of parasites per parasitophorous vacuole at 6, 24 
and 44 hr post-infection (prior to egress from the initial host cell). Confluent monolayers of ~5 x 
105 stable knockdown host cells in 60 mm dishes were infected with 106 T. gondii parasites. At 
least 100 vacuoles were counted per time point. Data are presented as mean ± SEM; n=5. 
 
Monitoring T. gondii egress upon treatment with TCA metabolites.  P30-GFP T. gondii 
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tachyzoites were incubated in quadruplicate with confluent monolayers of HFF cells within glass-
bottom 35 mm dishes and allowed to undergo 3 parasite divisions (8 tachyzoite per PV stage) 
prior to the addition of 50 µM lactate, aKG, or succinate, or a mixture of αKG and succinate, or 
the Ca2+ ionophore A23187 (10 µM) as a positive control of egress induction, to the culture 
media.  Dishes were followed by fluorescent microscopy within an environmental chamber that 
mimics incubator conditions (37 degrees C, 5% CO2) until parasite egress.  
 
P. yoelii 17XNL and P. berghei ANKA mouse studies. These experiments were conducted 
with the assistance of Satish Mishra, Ph.D. in the laboratory of Photini Sinnis, M.D. at the Malaria 
Research Institute, Bloomberg School of Public Health, Johns Hopkins University.   
Swiss Webster mice were infected with 2x105 P. yoelii 17XNL parasitized erythrocytes in 
200 µL of RPMI medium via intravenous injection. Following a standard 4-day Peters suppression 
test protocol (Knight and Peters, 1980), the treatment regimen began on day 1 (the same day the 
mice were infected) and mice were dosed once per day intravenously on days 1-3 with vehicle 
(20% DMA in saline [n=3] or 20% Kleptose HPB [n=2]); 10 mg/kg mPF4 (in saline [n=3], R&D 
systems); or 10 mg/kg C12 (in saline [n=4]). Parasitemias were determined on day 4 via Giemsa-
stained blood smears.  
C57BL/6 mice were infected with 2.5x104 P. berghei ANKA parasitized erythrocytes via 
intravenous injection. Mice were dosed once per day intravenously on days 1-4 with either 5 
mg/kg PMX1207 (in 20% DMA in saline [n=5]); 20 mg/kg PMX207 (in 20% Kleptose HPB [n=5]); 
or untreated (Control, n=5). Parasitemias were determined on days 5 and 7 via Giemsa-stained 
blood smears. 
 
T. gondii mouse studies. These studies were completed by Christopher D. Dupont in the 
laboratory of Christopher A. Hunter, Ph.D. at the School of Veterinary Medicine, University of 
Pennsylvania.  Age-matched female Swiss Webster mice were infected intraperitoneally with 103 
RH parasites engineered to express the model antigen Ovalbumin and the fluorescent protein 
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Tomato (RH-OVA-Tom; John, et al. 2009). Treated mice were administered 10 mg/kg Go6976 
daily beginning 1-hour post-infection.  Five days post-infection, mice were euthanized, and 
parasite burden in the spleen and peritoneal cavity was determined by flow cytometry. Statistical 
significance was determined using a two-tailed Mann-Whitney Test.  Data shown are compiled 
from three separate experiments. Experiments were performed at the University of Pennsylvania 
(UPenn) School of Veterinary Medicine in accordance with the guidelines of the UPenn 
Institutional Animal Care and Use Committees. 
PECS were obtained by peritoneal lavage with 5 mls of PBS (GIBCO).  Splenocytes were 
obtained by mashing spleens against a 40 µm cell strainer (Biologix) and resuspending in 
complete RPMI (RPMI 1640 (Mediatech), 10% fetal calf serum (GIBCO),  1X non-essential amino 
acids (GIBCO), 1X Penicillin Streptomycin (GIBCO), 1X beta-2-mercaptoethanol (GIBCO)).  Red 
blood cells were lysed by resuspending in lysis buffer (0.846% NH4Cl (Sigma-Aldrich)).  Cells 
were suspended in flow cytometry buffer (PBS, 0.2% bovine serum antigen (Sigma-Aldrich), 2mM 
EDTA (Invitrogen)) and analyzed using a FACSCanto (BD) or LSRII (BD) flow cytometer.  Data 
was analyzed using FlowJo 8.8.7 software (TreeStar) and Prism 4 software (GraphPad).   
CaMKII studies. U2OS cells were fractionated using Triton X-100. The cytoskeletal fraction was 
incubated with 100 nM recombinant rat CAMKII (NEB) in 1X NEBuffer for Protein Kinases 
supplemented with 200 µM ATP, 1.2 µM calmodulin and 2 mM CaCl2 and incubated for 1 h at 
37°C. 100 nM recombinant human calpain (Biovision) was added to the mixture and incubated for 
30 min at 37°C prior to separation by SDS-PAGE, transfer to PVDF membrane, and probing for 
a-spectrin (primary antibody gift from David Speicher) and anti-rabbit secondary antibodies 
conjugated to HRP (Sigma). 
 
Ca2+ studies. Erythrocytes were hypotonically lysed and loaded with 50 µM fura2-dextran prior to 
resealing and incubation with synchronous P. falciparum schizonts. Parasites infecting fura-2-
dextran-loaded erythrocytes were followed by fluorescent microscopy and plate-based 
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fluorometry throughout the life cycle to assess host erythrocyte cytoplasmic [Ca2+] via the 
equation: [Ca2+] = Kd Q (R-Rmin)/ Rmax-R), where R represents the fluorescence intensity ratio at 
340 nm/380 nm excitation and emission at 510 nm. Data are presented as mean fluorescence ± 
SEM; n=3. Representative images are shown. 
U2OS cells were transduced using the Premo Cameleon Calcium Sensor (Life 
Technologies) according to manufacturer’s instructions to facilitate cytoplasmic expression of 
YC3.6 prior to synchronous T. gondii infection. Host [Ca2+] was measured throughout the parasite 
life cycle via FRET microscopy on a Leica DMI6000B and FRET-based fluorometry to assess 
[Ca2+] as a function of CFP/YFP emission ratio. Data are presented as mean fluorescence ± 
SEM; n=3. Representative images are shown. 
 
Assessing background (digestive vacuole) FRET-based or Fura-2 fluorescence.  In order to 
determine CKAR or Fura-2 signal that was attributable to uptake into the parasite digestive 
vacuole, sorbitol-synchronized 3D7-CKAR parasites or 3D7 parasites infecting erythrocytes 
loaded with Fura-2 dextran were selectively removed from their host cells using 0.1% saponin in 
PBS at 3 hour increments throughout the intracellular cycle, washed, and plated in quadruplicate 
prior to assessment of plate-based fluorescence as described in the main experimental 
procedures. Representative images were also taken on a Leica DMI6000B epifluorescent 
microscopy.  Data are presented as mean +/- SEM; n=4.  
 
CKAR transfection and PKC activity measurement. CKAR plasmid (Addgene) was transfected 
into U2OS cells using Lipofectamine 2000 (Life Technologies) according to manufacturer’s 
instructions. 3D7-CKAR construct was generated via addition of a minimal export PEXEL motif N-
terminal to CKAR (Marti, et al 2004; Hiller, et al 2004) following PCR amplification from the CKAR 
plasmid. This was achieved via amplification of the N-terminus of the exported protein KAHRP 
(PF3D7_0202000) from cDNA of asynchronous 3D7 parasite cultures and recombination with the 
CKAR motif into the P. falciparum expression vector p-HHVPatt using MultiSite Gateway (Marti et 
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al., 2004). Constructs were transfected into the P. falciparum 3D7 line and selected using 10 nM 
WR99210 (an inhibitor of dihydrofolate reductase; Fidock and Wellems, 1997). 3D7-CKAR 
transgenic parasites and T. gondii-infected U2OS cells expressing CKAR were cultured under 
standard conditions and assessed for PKC activity via FRET-based fluorometry as a function of 
YFP/CFP emission ratio and FRET imaging on a Leica DMI6000B. Data are presented as mean 
± SEM; n=4. Representative images are shown. 
 
Parasite IC50 determination.  These studies were completed in collaboration with Melissa S. 
Love at the University of Pennsylvania.  Compounds were assayed for 72h, after which the 
cultures were fixed with a solution of 4% paraformaldehyde and 0.008% glutaraldehyde in PBS 
prior to permeabilization with 0.25% Triton X-100, and 5 µM SYTOX Green Nucleic Acid Stain 
and flow cytometry analysis (Accuri C6 Flow Cytometer with C-Sampler). IC50 curves were 
generated using GraphPad Prism.  
 
Hemolysis. These studies were completed by Melissa S. Love at the University of Pennsylvania.  
Following removal of culture supernatant before fixing and transferring to a clear-bottom plate. 
Absorbance at 541 nm was measured and compared to a standard curve generated from Triton 
X-100-lysed erythrocytes. 
 
Platelet activation. Platelets were collected from C57BL/6 mice (WT), homozygous PF4 
knockout mice (PF4 KO), and transgenic mice overexpressing human PF4 (hPF4+) (Eslin et al., 
2004a) and added to cultures either with or without pre-activation ex vivo with 5 µM AYP. 
Parasitemia was assessed via flow cytometry after 24 hours treatment. 
 
Parasite membrane potential assays. These studies were completed in collaboration with 
Melissa S. Love at the University of Pennsylvania.  Parasite-infected erythrocytes were incubated 
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at 37°C for 30 minutes with 1 µM rhodamine 123 (for parasite plasma membrane potential), 0.2 
µM rhodamine 123 (for parasite mitochondrial potential) (del Pilar Crespo et al., 2008), or 10 nM 
LysoTracker Red (for digestive vacuole potential). After pre-incubation, parasites were treated for 
4 hours with the test compound, a 10 µM mixture of the ionophores monensin (Sigma) and 
nigericin (Calbiochem) as a positive control of membrane potential perturbation, or left untreated 
and then analyzed via fluorescence microscopy on a Leica DMI6000 B. 
 
Fluorescence microscopy and quantification of digestive vacuole lysis. Erythrocytes 
infected with synchronous cultures of PMII-GFP expressing parasites were treated at 30 hours 
post invasion (hpi) and fixed at the indicated time points, stained with Hoechst and imaged by 
fluorescence microscopy. Cells were also analyzed on an Amnis ImageStream X high-resolution 
flow cytometer with gating for Hoechst-positive cells to isolate infected cells (Muskavitch et al., 
2008; Ortyn et al., 2007).  
 
smHDP screen. These studies were completed in collaboration with Melissa S. Love at the 
University of Pennsylvania.  Synchronized parasites were treated with 500 nM of each smHDP for 
72 hours. Cells were then fixed and assayed for parasitemia via flow cytometry. Compounds were 
deemed hits if they caused ≥80% parasite death, as compared to a 500 nM chloroquine-treated 
positive control. The Z-factor was calculated using the equation  where µ 
represents the means and σ represents the standard deviations of the positive (p) or negative (n) 
controls (Zhang et al., 1999). 
 
HDP screen and assay for hemolysis. These studies were completed by Melissa S. Love at the 
University of Pennsylvania.  P. falciparum parasites (3D7 strain) were cultured as described 
previously. Synchronized parasites were treated with 15 µM of 9 platelet-, neutrophil-, or 
!  
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lymphocyte-derived proteins containing HDP-domains or properties: Regulated upon Activation, 
Normal T-cell Expressed, and Secreted (RANTES, ProSpec); Platelet Factor-4 (PF4, 
Haematologic Technologies Inc.); Fibrinopeptide-A (FP-A, AnaSpec); Fibrinopeptide-B (FP-B, 
AnaSpec); Human Neutrophil Peptide-1 (HNP-1, AnaSpec); Human Neutrophil Peptide-2 (HNP-2, 
AnaSpec); Cathelicidin (LL-37, AnaSpec); Lymphotactin (ProSpec); Lactoferrin (ProSpec). 15 µM 
melittin, the major active component of bee venom, was used as a positive control for HDP-killing 
of parasites with complete hemolysis. Parasite death was normalized to a 500 nM artesunate 
control. Parasites were treated for 72 hours, and then fixed and assayed for parasitemia via flow 
cytometry. Hemolysis was measured by removing 50 µL from each well (100 µL total in a 96-well 
plate) before fixing and transferring to a clear-bottom plate. Absorbance at 541 nm was measured 
and compared to a standard curve generated from Triton X-100-lysed erythrocytes (4% 
hematocrit serially diluted by 2). 
 
Fluorescence microscopy of PMX496. Erythrocytes infected with synchronous cultures of wild 
type parasites (3D7) were treated at 30 hpi with 250 nM of the intrinsically fluorescent PMX496 
(green: PMX496, blue: parasite nuclei) and followed at specified time points on a Leica DMI6000 
B.  
 
Protamine sulfate studies. hPF4 immunofluorescence was assayed as described above with 
pretreatment of cultures with 5 mM protamine sulfate or mock (DMSO) for 30 min prior to hPF4 
treatment. 
 
Western blot analysis of PF4 accumulation. Synchronous cultures of P. falciparum-infected 
erythrocytes were treated with 10 µM PF4 then 0.1% saponin to separate erythrocyte fractions 
from parasite material. Samples were run by standard SDS-PAGE, transferred to Immobilon 
Transfer PVDF membrane and incubated with 1:1000 primary antibody to human PF4 and 
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1:10000 anti-mouse secondary antibody. Input of total cell lysates was used as a loading control, 
using a primary antibody to flotillin and an anti-rabbit secondary antibody. 
 
Transmission Electron Microscopy. Synchronous cultures of P. falciparum parasites were 
magnet-purified at ~25 hpi and allowed to sit for 6 hours prior to a 10-min exposure to 10 µM 
PF4, 500 nM PMX207 or PMX1207. DMSO was used as a negative control. Samples were frozen 
in an Abra high-pressure freezer. This material was freeze substituted in 2% OsO4 in anhydrous 
acetone and embedded into Epon. Images were collected at 120KeV on a FEI Tecnai12 
equipped with a Gatan 894 2k camera. Images were captured by Dewight R. Williams, Ph.D. at 
the Electron Microscopy Core at the University of Pennsylvania. Tilt series were taken +/- 70° in 
3° increments at 6500x magnification. Tilt images were decimated by a factor of 2 and initially 
aligned by cross-correlation in FEI’s inspect3D. Tomograms were constructed from fiducially 
aligned stacks, orthogonal merged axes, and subsequent serial tomograms joined in the IMOD 
package “etomo”. Montage images taken with 10x10 sampling at 3200x magnification were 
aligned with blendmont. 
 
Texas Red Dextran-loaded erythrocyte analysis of DV lysis. Erythrocytes were lysed and 
resealed as described previously in the presence of 10 µM Texas Red Dextran prior to challenge 
with synchronous magnet-purified cultures of P. falciparum-schizont stage parasites.  Infected 
erythrocytes containing Texas Red Dextran were treated at 30 hpi with hPF4, C12, or smHDPs 
as previously described and imaged on a Leica DMI6000B epifluorescent microscope to assess 
lysis of the parasite DV, denoted by Texas Red Dextran dispersion throughout the parasite body.  
Infected Texas Red Dexran-loaded cells were also subjected to gametocytogenesis as previously 
described (Fivelman et al., 2007) and treated with hPF4 or PMX1207 at stage 2 prior to 
fluorescent microscopy analysis of DV lysis. 
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Statistical analyses. Statistical significance of unruptured vacuole persistence, in vitro 
parasitemias, FRET-based signal for CKAR activity or YC3.6 Ca2+ studies, and Fura-2 signal with 
a one-way ANOVA with Dunnett’s post-hoc test. In vivo mouse parasitemias were analyzed with 
one-tailed paired Student’s t-tests and mouse survival was analyzed using the Mantel-Cox log-
rank test. 
 
 
 
 
	  
	  
27	  
III. Progressive dismantling of the host cytoskeleton facilitates 
Apicomplexan parasite exit: 
Targeting host protease activity for death by entrapment 
	  
We employed a proteomic approach to understand the molecular basis for the large 
changes in the infected erythrocyte cytoskeleton upon schizont maturation and egress. 
Three proteomes were compared via mass spectrometry-based analysis: (i) the plasma 
membrane proteome from uninfected erythrocytes, (ii) the erythrocyte/PV membrane 
proteome from infected erythrocytes prior to parasite egress (~40 hpi, 8 hours prior to 
egress), and (iii) the erythrocyte/PV membrane proteome isolated from infected 
erythrocyte post-rupture vesicles. Although there certainly could be important cytosolic 
protein modifications during parasite egress, changes in the soluble proteome were 
largely obscured by hemoglobin, thus we specifically analyzed proteins in only the 
membrane fractions. 
Proteomic analysis of changes to the host membrane proteome during parasite 
egress 
We developed a differential fractionation strategy to isolate these three host 
membrane proteomes (Figure 1A). Uninfected erythrocyte membranes were isolated by 
hypotonic lysis followed by ultracentrifugation. To isolate extraparasitic membranes 
(PV/erythrocyte) from infected erythrocytes, magnet-purified schizonts were separated 
from uninfected erythrocytes (Greenbaum et al., 2002), then treated with saponin, which 
at low concentrations (0.02%) selectively permeabilizes the erythrocyte/PV sparing the 
parasite plasma membrane (Chandramohanadas et al., 2009). The erythrocyte/PV 
membranes were then enriched by low speed centrifugation to remove whole parasite 
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cells and further isolated by ultracentrifugation as described elsewhere 
(Chandramohanadas et al., 2009). To isolate post-rupture vesicle membranes from 
infected erythrocytes, highly synchronous cultures of late-stage infected erythrocytes 
were magnet-purified and allowed to naturally egress in culture media. Extracellular 
merozoites were then separated from culture media (containing post-rupture membrane 
vesicles) by low speed centrifugation (1,500xg). Post-rupture membrane vesicles were 
then isolated from the media by ultracentrifugation at 200,000xg for 2 hours. For 
comparison, we show FM4-64 stained images of uninfected erythrocytes; parasite 
culture media collected immediately after rupture that contains both intact uninfected 
erythrocytes and post-rupture vesicles (red), as well as released merozoites stained with 
Hoechst (blue); and purified post-rupture vesicles purified from the media after parasite 
egress (red) (Figure 1B). We observed little parasite contamination in either the infected 
erythrocyte membrane preparation or the samples enriched for post-rupture vesicles. To 
confirm that we achieved purification of extraparasitic membrane material, we show the 
enrichment of the erythrocyte membrane marker Band 4.9 and the concomitant loss of 
GFP from a parasite line expressing cytosolic GFP (Figure 1C). 
To identify and compare proteins from these three proteomes we employed an SDS-
PAGE/MS approach akin to the geLC-MS/MS approach used by the Mann group 
(Shevchenko et al., 2006), where samples were first separated by one-dimensional SDS 
PAGE, then individual gel slices across the entire lane were excised and subjected to 
LC/MS/MS analysis. The uninfected, infected erythrocyte and post-rupture vesicle 
membranes were first delipidated by incubating with sodium acetate/ethanol for 1 hour at 
room temperature, which enhanced the recovery of peptides in the subsequent LC/MS 
analysis (Pasini et al., 2006). The polypeptides were then separated by SDS-PAGE and 
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stained with colloidal Coomassie. Initially we observed that the uninfected erythrocyte 
and the infected erythrocyte membrane proteome migration pattern by Coomassie to be 
comparable, apart from a major reduction in spectrin band intensity in the infected 
erythrocyte membrane sample. However, the migration pattern for the post-rupture 
vesicle membrane proteome was markedly different (Figure 2A).  
Thirty-four individual gel slices were excised throughout the SDS-PAGE lanes in 
order to identify proteins and assess their relative size for each of the three proteomes 
(as graphically depicted in Figure 2A). Each excised gel band was digested with trypsin, 
peptides were analyzed by LC/MS/MS and peptides were matched to proteins using 
SEQUEST. A total of 33,386 entries from the NCBI database were searched for protein 
identification. Proteins that had at least three peptides from a minimum of two 
independent MS analyses were considered as confident ‘hits’. Most datasets had a false 
discovery rate of < 2. Although the Coomassie stained gels only revealed a few major 
proteins, we identified approximately 250 proteins from each sample (Figure 4B), which 
is commensurate with prior proteomic studies of human erythrocytes (Pasini et al., 
2006);  thus most proteins were present at a level below the level of detection by 
Coomassie. Furthermore, proteins identified were well distributed throughout the SDS-
PAGE gel (Figure 2B). Spectral counting analysis was used to compare the ratios of 
total protein abundance, which revealed that only ~15% of the protein hits changed more 
than 3-fold (first two bars in histogram), while the relative abundance of the remaining 
~85% of proteins was within 3-fold (0.3-1 and 1-3) amongst all three proteome samples. 
This data indicates that although the Coomassie stained gels showed different patterns- 
primarily due to huge losses of a few major erythrocyte membrane proteins such as 
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spectrins, the abundance of the majority of infected erythrocyte membrane proteins 
remained unchanged during parasite egress (Figure 2C).  
Adducin is lost from the host cytoskeleton 10-15 hours prior to parasite egress 
In comparing the proteomes of uninfected erythrocytes and infected erythrocytes, we 
observed that a subset of host proteins identified with high confidence in the uninfected 
membrane samples were absent or highly reduced (>>3 fold change) in both the 
infected erythrocyte and post-rupture vesicle membranes (Table 1), suggesting that 
major cytoskeletal modifications may be occurring far earlier in the erythrocytic life cycle. 
We observed that erythrocyte adducins, tropomyosin and Rac1 disappear from the 
membrane fraction around 35 hpi, which was striking as these proteins have been 
shown to be important for the integrity of the cytoskeleton (Kalfa et al., 2006). Direct loss 
of adducin via mutations or through the loss of Rac1/2 has been shown to disrupt 
spectrin/actin junctions,(Kalfa et al., 2006) leading to spherocytosis and increased 
hemolysis in in vivo mouse models (Gilligan et al., 1999; Robledo et al., 2008). Western 
blot analysis of infected erythrocyte membrane fractions confirmed that a-adducin is 
present through the first two-thirds of the intraerythocytic life cycle but is lost from the 
host cytoskeleton at ~35 hpi (Figure 3A). These data was corroborated using 
immunofluorescence, which showed that adducin is localized to the plasma membrane 
of uninfected and early stage infected erythrocytes (up to 30 hpi), but disappeared 
around 35 hpi (Figure 3B). Uninfected erythrocytes also showed an abundance of 
cytoplasmic adducin staining, which is diminished in infected cells possibly due to 
parasite digestion of host cytoplasm. We also show that adducin loss from the 
cytoskeleton is not dependent on calpain, as calpastatin loading into hypotonically lysed 
and resealed erythrocytes did not prevent adducin loss from the membrane fractions of 
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infected erythrocytes by western blot analysis (Figure 3C). The loss of a-adducin, as 
well as tropomyosin and Rac1 following schizogony suggests that cytoskeletal 
dismantling in preparation for egress begins much earlier than previously thought.   
Analysis of proteome changes reveals global proteolysis of the host cytoskeleton 
during parasite egress 
Considering the previously proposed role of proteases in parasite egress, we next 
focused our analysis of the proteomic data on proteins that appeared to be proteolyzed 
during egress. To do this, we searched for proteins that appeared at significantly smaller 
sizes than expected in the post-rupture vesicle membrane proteome compared to the 
infected erythrocyte and uninfected erythrocyte proteomes, as they likely represented 
proteins proteolytically processed during parasite egress. We used several overlapping 
methods to determine proteins that appeared smaller in size. Spectral counts for each 
protein were plotted against their position in the actual gel lane to create 
“chromatograms” representing their migration pattern in the SDS-PAGE gel (Figure 4A) 
for each proteome, which provided a simple yet efficient tool to compare progressive 
changes in protein distribution patterns between the three proteomes. Although 
cytoskeletal proteins such as a-spectrin, ankyrin, actin, and band 4.1 were identified at 
their expected molecular weight in the infected erythrocyte sample, these proteins were 
also detected at lower molecular weight areas of the chromatogram in the post-rupture 
vesicle membrane samples, suggesting that they had been proteolyzed. It is worth 
noting that ankyrin had been previously shown to be proteolyzed by crude parasite 
lysates (Raphael et al., 2000). However, the majority of proteins, such as flotillin-1 and -
2, showed no apparent cleavage, as shown by the lack of any low-molecular weight 
fragments (Figure 4A, top panel). This revealed that although several proteins from the 
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post-rupture vesicle membrane proteome appeared smaller than their predicted size 
(Figure 4A, lower panel), the majority of proteins did not undergo any proteolytic 
cleavage during rupture and appeared at their expected molecular weight in all three 
proteome samples.  
Using this method, we estimated the number of proteolyzed proteins in all three 
proteomes. We observed a doubling in the number of proteolyzed proteins (2% to 5%) 
from uninfected to infected erythrocyte membrane proteome, however, the magnitude of 
proteolysis was significantly increased in the post-rupture vesicle proteome (12%) 
(Figure 4B). Proteins that had undergone proteolysis were then classified into functional 
categories: the majority of these proteins (approximately 60%) were associated with or 
members of the cytoskeleton (Figure 4C). To date, most of these cytoskeletal proteins 
have not been reported to be proteolyzed in uninfected erythrocytes or during P. 
falciparum infection.  
To confirm our predictions, we conducted western blot analysis of potential 
proteolyzed hits over a timecourse throughout the parasite life cycle (10-hour increments 
from 10-40 hpi), in comparison to uninfected erythrocytes (U) and post-rupture vesicles 
(R). Processing of several proteins at the time of rupture that were found to be 
proteolyzed from the MS data were confirmed, including the key cytoskeletal proteins 
α/β-spectrins and ankyrin-1 (Figure 5A), as fragments appeared in the post-rupture lane 
that were similar in size to those found in the MS analysis (see Figure 4A). Several lipid 
raft-associated proteins including the flotillins were protected from proteolysis, and 
served as loading controls for the rest of the western blots shown in Figure 5A. 
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We also identified the presence of several proteases in the infected erythrocyte 
proteome (Table 2). Notable among these was host calpain-1 that was present only in 
the late-stage infected erythrocyte membranes and post-rupture vesicle membranes. 
Calpain-1 activation and its corresponding association with the erythrocyte membrane 
are important for malaria parasite egress, as we described recently (Chandramohanadas 
et al., 2009). We investigated whether calpain activity could account for the degradation 
of much of the observed cytoskeletal proteolysis during parasite egress, via incubation 
with erythrocyte membrane fractions in the presence of Ca2+ for 30 minutes. We provide 
in vitro data validating that, indeed, activated calpain-1 can cleave a whole spectrum of 
cytoskeletal proteins, generating fragments of similar size to those found in our MS and 
western blot analyses of post-rupture vesicles (Figure 5B). In addition to calpain-1, 
parasite-derived SERA proteins, which have been postulated to have a role in egress, 
were abundantly found in our infected erythrocyte and post-rupture vesicle membrane 
samples (Yeoh et al., 2007).  
Discussion 
Our proteomic data revealed that several host proteins, including most prominently 
α/β-adducin, disappeared from the host erythrocyte cytoskeleton significantly prior to 
parasite egress. Targeted disruption of adducin genes has been long known to result 
increased fragility of the erythrocyte membrane that ultimately leads to spherocytosis 
and increased hemolysis in mice (Chen et al., 2007; Gilligan et al., 1999; Robledo et al., 
2008). Thus this initial weakening of the cytoskeleton via the loss of the adducins 
(perhaps the loss of tropomyosin and Rac1 as well) may be required for the later 
destruction of membrane integrity to permit facile parasite escape. We determined that 
α-adducin loss from the erythrocyte cytoskeleton is both temporally and mechanistically 
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distinct from the changes enacted on the host cell at the time of egress by host calpain-
1. This suggests a new mechanism used by malaria parasites, occurring 15-20 hours 
prior to parasite egress in order to prepare the infected erythrocyte for rupture. This 
process may be mediated by parasite kinases to modify host proteins during egress 
since phosphorylation of cytoskeletal proteins has been shown to result in progressive 
changes to the cytoskeletal network (Lu et al., 1985; Manno et al., 1995; Soong et al., 
1987). Though parasite kinases have been shown to be exported into the host cell 
(Nunes et al., 2007; Vaid et al., 2010), a direct link between parasite kinase activity and 
infected erythrocyte cytoskeletal changes during egress has yet to be explored. 
In addition to the loss of α-adducin, our proteomics data revealed that a significant 
proportion of erythrocyte cytoskeletal proteins were proteolyzed upon parasite egress. In 
fact, in post-rupture vesicle membranes, the total amount of spectrins diminished to 
~10% of that found in uninfected erythrocyte membranes. In total, more than 60% of the 
proteins that were found to be proteolyzed were associated with the host cytoskeleton 
including most prominently the spectrins, ankyrin, and actin, suggesting that global and 
pathological proteolysis of the host cytoskeleton occurs during the parasite egress 
process (~48 hpi). Several proteases were also found associated with the infected 
erythrocyte and post-rupture vesicle membranes, including host calpain-1, an essential 
enzyme that apicomplexan parasites utilize for egress (Chandramohanadas et al., 
2009). We show that calpain-1 can proteolyze most cytoskeletal proteins during egress, 
which likely accounts for the striking breakdown of the host erythrocyte membrane 
around the parasite. Although calpain-1 is capable of proteolyzing many of the 
cytoskeletal proteins, it is possible that other putative parasite proteases such as SERA 
family proteases can also perform this function; importantly, SERA5/6 were found to be 
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in abundance on infected erythrocyte membranes and post-rupture vesicles. Although 
there is little data concerning the proteolytic activity of SERA proteins or for their direct 
role during parasite egress from the erythrocyte, it is also possible that they contribute to 
the egress process through destabilization of the host membrane via a non-proteolytic 
role.  
Table 1 
 
Table 1. Proteins that are absent/reduced in infected erythrocyte and/or post-rupture vesicle 
membranes.  List of high abundance proteins that were identified in the uninfected erythrocyte membranes 
and absent or reduced in the infected erythrocyte and post-rupture vesicle membrane samples. 
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Table 2A. Proteases identified in the proteomic analyses from infected 
erythrocyte membranes (I). 
	  
Table 2B. Proteases identified in the proteomic analyses from post-rupture 
vesicle membranes (R). 
 
Table 2. Proteases identified from infected erythrocyte and post-rupture vesicle membrane samples. 
A list of proteases identified with four or more unique peptides from (A) infected and (B) post-rupture vesicle 
membrane proteomes are listed. 
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Figure 1. Fractionation strategy for comparing uninfected 
erythrocyte, infected erythrocyte and post-rupture vesicle membrane 
proteomes.  
To understand the global changes in the erythrocyte membrane proteome upon parasite egress, parasite-
infected (I) and post-rupture vesicle membranes (R) were isolated and compared with uninfected erythrocyte 
membranes (U). Newly replicated parasites (P) and the food vacuole following schizogony (FV) are also 
shown. (A). Uninfected erythrocyte membranes were prepared by hypotonic lysis and ultracentrifugation. 
The infected erythrocyte membrane proteome was prepared by saponin treatment of magnet-purified 
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schizonts and ultracentrifugation. To prepare post-rupture vesicle membranes, we used a differential 
centrifugation strategy to purify vesicles from media following parasite egress (see methods for more 
details). All the samples were solubilized in Laemmli buffer, resolved by SDS-PAGE and visualized by 
colloidal Coomassie staining. 34 slices were excised from each proteome for analysis by mass 
spectrometry. (B). To illustrate the efficiency of the fractionation strategy, the purification of post-rupture 
vesicles was visualized by microscopy. Each fraction was stained with FM4-64 for membrane staining and 
DAPI for DNA. Panel 1: Uninfected erythrocytes; Panel 2: crude media just after parasite rupture from 
infected erythrocytes containing merozoites (arrow marks), post-rupture vesicles (arrowheads) and intact 
erythrocytes (broken line); Panel 3: purified post-rupture vesicles derived from parasite egress. (C). 
Selective enrichment of infected erythrocyte membranes from parasite material was also confirmed by 
western blot analysis using a transgenic parasite line expressing cytosolic GFP. Protein from whole infected 
erythrocytes (I), purified parasite cells fractionated by low speed centrifugation from saponin-treated infected 
erythrocytes (P), or post-rupture vesicles fractionated from media after parasite egress (R) were separated 
by SDS-PAGE. Efficient isolation of infected erythrocyte membrane material was determined by western 
using a parasite cytoplasmic marker (anti-GFP) and a human erythrocyte membrane marker (anti-Band 4.9). 
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 Figure 2. Comparative proteomic analysis of the erythrocyte 
membrane proteome during parasite egress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (A). Infected erythrocyte membranes (I) and post-rupture vesicles derived from parasite egress (R) were 
isolated and compared with uninfected erythrocyte membranes (U). Samples for the proteomic analysis 
were resolved on a 4-12% SDS-PAGE gel and stained with colloidal Coomassie. 34 slices were excised 
from each sample lane, digested with trypsin, extracted, and analyzed by LC/MS/MS mass spectrometry-
based sequencing. The overall migration pattern for the post-rupture vesicle membrane proteome was 
	  
	  
40	  
different, as the characteristic high molecular weight spectrin doublet appeared to be degraded and with the 
appearance of more small molecular weight bands. (B). Peptides from each gel slice were sequenced by 
mass spectrometry and the percentage distribution of identified proteins through the SDS-PAGE lanes for all 
samples (U, I, and R) were expressed in a heat map format. Red color indicates high percentage of peptides 
per protein (10%) while yellow indicates minimum (0%). This representation indicates that proteins were well 
distributed throughout the SDS-PAGE gel. (C). Spectral counting was used to compare the relative 
abundance of each protein from the three proteomes. The total number of peptides was summed for each 
identified protein in the infected erythrocyte and post-rupture vesicle proteome samples and was individually 
compared to the uninfected preparation to determine fold changes in relative protein abundance among the 
three proteomes. The abundance of most proteins remained similar (within a 3-fold difference) among the 
three proteomes, whereas a small proportion (~10%) showed markedly lower abundance in the post-rupture 
vesicle proteome. 
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Figure 3. Loss of adducin from the erythrocyte cytoskeleton prior to 
parasite escape is calpain-independent.  
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 Figure 4. Proteomic profiling shows extensive cytoskeletal protein 
proteolysis during parasite egress. 
 
(A). To determine proteins that were proteolytically processed, the spectral count for each protein was 
plotted against the corresponding gel slice number (and hence the apparent molecular weight) judged from 
its migration in the SDS-PAGE gel. Several proteins appeared smaller than their expected molecular weight 
as indicated by a second peak in the chromatogram corresponding to a lower molecular weight as seen in α-
spectrin, band 4.1 and actin. Abundance of the smaller species was universally increased in the post-rupture 
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vesicle proteome sample. Otherwise, the majority of the proteins showed no major difference in abundance 
and molecular weight as exemplified by flotillin-1. (B). Proteolysis of host membrane proteins significantly 
increases at egress. Number of processed proteins identified from the uninfected (U), infected erythrocyte (I) 
and post-rupture vesicle (R) membrane proteomes is expressed as a percentage of total proteins identified. 
(C). Proteins that were processed in the post-rupture vesicle erythrocyte membrane were classified 
according to their functions as obtained from the human proteins reference database (www.hprd.org), and 
corresponding Gene Ontology (GO) annotation. 
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Figure 5. Validation of calpain-dependent cytoskeletal processing 
during parasite rupture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A). Western blot analysis from uninfected erythrocyte (U), infected erythrocyte throughout the life cycle (10-
40 hpi), and post-rupture vesicle (R) membranes was used to validate the proteolytic processing of 
candidate proteins. Analysis of α-spectrin, β-spectrin and ankyrin-1 showed major degradation of target 
proteins only in the post-rupture vesicle proteome sample whereas many proteins, such as flotillin (shown as 
loading controls underneath each blot) showed no proteolytic processing. (B). Erythrocyte membranes 
treated for 30 min with activated human calpain-1 were able to recapitulate the processing observed in post-
rupture vesicles. Western blot analysis of calpain-mediated processing is shown for α-spectrin, β-spectrin, 
and ankyrin-1.  
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Figure 6. New model for parasite driven modifications to the host 
cytoskeleton during parasite egress. 
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IV. Host GPCR signaling necessary for parasite-mediated cytolysis: 
Thwarting host signaling to stop them in their tracks 
Parasite-induced host cell cytolysis has been suggested to be a two-step, Ca2+-
dependent process (Salmon et al., 2001; Wickham et al., 2003b) requiring both host cell 
ion loss (Moudy et al., 2001) and increased membrane poration (Abkarian et al., 2011; 
Glushakova et al., 2010). Recent reports implicate the activity of parasite-derived 
proteins including: a perforin-like protein (Kafsack et al., 2009), a kinase (Dvorin et al., 
2010), and proteases (Arastu-Kapur et al., 2008; Yeoh et al., 2007) though reports of 
host protein contribution to this process are limited. We have recently shown that the 
host-derived protease calpain is required for exit of both P. falciparum and T. gondii and 
functions to proteolyze the actin cytoskeleton just prior to cytolysis (Chandramohanadas 
et al., 2009; Millholland et al., 2011). Furthermore, we have identified calpain-
independent loss of adducin from the host erythrocyte actin cytoskeleton prior to P. 
falciparum exit (Millholland et al., 2011). Given the temporal separation of these striking 
changes to the host cytoskeleton during the last phase of the intracellular cycle, we 
hypothesized that a complex host pathway may connect these changes and result in the 
disintegration of the host plasma membrane. Identification of host proteins necessary for 
parasite infection may offer an untapped resource of antiparasitic targets. 
Host RNAi screen reveals a pathway necessary for T. gondii-mediated cytolysis 
To identify host genes essential for parasite-mediated cytolysis, we performed an 
RNAi screen in U2OS cells (highly transfectable T. gondii host cells) focused on 
canonical Ca2+-signaling components, given our earlier studies that implicated host 
calpain in T. gondii and P. falciparum exit (Chandramohanadas et al., 2009, Millholland 
et al., 2011). To circumvent the potential for functional redundancy between host gene 
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isoforms, we tested pooled siRNAs for simultaneous knockdown of gene families, as 
well as individual genes present in both U2OS cells and erythrocytes. This primary 
screen included 45 individual gene knockdowns and 11 multi-isoform knockdowns 
(Tables 3,4). Pooled siRNAs (three siRNAs/gene) were arrayed in quadruplicate, 
reverse-transfected into U2OS cells, and infected 24 hours post-transfection with 
transgenic T. gondii tachyzoites (MOI of 0.1) that constitutively secrete GFP into the PV 
space, allowing for facile identification of parasite doublings as a function of life cycle 
progression (P30-GFP; Figure 7A, Figure 8; (Striepen et al., 1998). siRNAs against 
calpain small subunit (capns1) and a scrambled oligo (Scr) were included as positive 
and negative controls, respectively. Knockdown efficiency was maximal at 72 hours 
post-transfection, which corresponded with parasite-mediated cytolysis in this cell type 
(~50 hpi). Following synchronous T. gondii infection (Kafsack et al., 2004), plates were 
fixed and imaged at 6, 24, 44, or 60 hpi to assess parasite life cycle progression through 
cytolysis. Genes involved in parasite-mediated cytolysis showed an accumulation of PVs 
containing >64 parasites at 60 hpi upon knockdown (Z score +1.5, p < 0.05), ~10 hours 
after host cell rupture typically occurs in this cell type.  
From this screen, we initially identified 5 gene families whose knockdown blocked 
parasite-mediated host cell cytolysis: calmodulin (CaM), Ca2+/calmodulin dependent 
kinases (CaMK), Gα subunits (Gα), phospholipase C (PLC) and protein kinase C (PKC) 
(Figure 7B). To deconvolute the specific genes required for parasite-mediated cytolysis 
from these gene family hits, we tested two unique siRNAs targeting individual and pairs 
of genes (Figure 7C, Table 5). We determined that single knockdown of gnaq 
(p<0.002), and knockdown of the gene pairs prkca/prkcb (p<0.002), plcb1/plcg1 
(p<0.002), calm1/calm2 (p<0.05) and camk1/camk2a (p<0.05), showed a statistically 
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significant and correlated accumulation of unruptured PVs at 60 hpi (r=0.91; Figure 7D). 
Stable shRNA-mediated knockdown of these genes had no effect on parasite doublings, 
reinforcing their function in cytolysis rather than parasite replication (Figure 7E). shRNA 
knockdown efficiency using multiple oligos was measured by western blot analysis of 
total protein as compared to scr (Figure 7F). Representative images are shown for 
shRNA knockdown cell lines that resulted in an accumulation of unruptured PVs in 
comparison to controls (scr) or negatives (prkaca/prkacb) that show newly reinvaded 
parasites at 60 hpi (Figure 7G). 
Immunodepletion studies indicate conserved host protein function in P. 
falciparum-mediated cytolysis 
We next investigated whether the protein products of the validated gene hits in T. 
gondii functioned similarly in P. falciparum-induced erythrocyte cytolysis, via antibody-
mediated depletion studies. To do this, erythrocytes were hypotonically lysed prior to 
incubation with target antibodies preconjugated to sepharose beads. Removal of the 
target protein-antibody conjugates were achieved via centrifugation and manipulated 
erythrocytes were hypertonically resealed prior to P. falciparum infection. Efficiency of 
target protein immunodepletion in erythrocytes was determined by western blot and only 
immunodepletions showing >80% knockdown were further analyzed (Figure 9A; 
(Chandramohanadas et al., 2009). Synchronous P. falciparum parasites were assessed 
for life cycle progression by Giemsa smear (Figure 9B) and flow cytometry of DNA 
content (Figure 9C; Figure 10) to distinguish blocked multinucleated schizonts from 
newly invaded, ring-form parasites with a single nucleus. Immunodepletion of Gαq, 
PLCβ1, CaM-1, or the simultaneous immunodepletion of both PKCα and PKCβ resulted 
in an accumulation of schizont stage parasites and a lack of newly invaded rings at 60 
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hpi, indicating a block in parasite-mediated cytolysis and corroborating the results of our 
RNAi screen in T. gondii host cells. To assess parasite viability, trapped parasites were 
mechanically released from depleted host cells and assessed for their invasive capacity 
via flow cytometric quantitation of mononuclear ring-stage parasites 12 hours following 
mechanical release (Figure 9D). Parasites trapped within erythrocytes were able to 
recover invasive capacity upon needle-shearing only up to 54 hpi, indicating that 
parasite death likely occurs following 6 hours of blocked cytolysis. 
Host PKC is Activated During Schizogony to Remove Adducin from the Host 
Cytoskeleton 
As PKC is a major downstream effector of Gαq-coupled GPCR signaling via PLC-
mediated generation of diacylglycerol (DAG; (Castagna et al., 1982; Rhee et al., 1989) 
and PKC inhibitors showed potent antiparasitic activity and the ability to block parasite-
mediated cytolysis in vitro (Figure 12A), we were interested in understanding the role of 
this critical host enzyme in parasite life cycle progression. To measure host PKC activity 
during the P. falciparum life cycle, we generated a transgenic P. falciparum line that 
secretes a FRET-based PKC activity indicator (CKAR; (Violin et al., 2003) into the 
infected erythrocyte cytoplasm (3D7-CKAR) via expression of a chimeric construct with 
an N-terminal signal peptide and PEXEL motif (Gallegos et al., 2006; Hiller et al., 2004; 
Marti et al., 2004; Violin et al., 2003). Figure 11A displays the specificity of the CKAR 
reporter for PKC activity with representative positive control FRET images (maximal 
FRET signal) of 3D7-CKAR-infected erythrocytes treated with the PKC agonist phorbol 
myristate acetate (PMA) and negative control images (minimal FRET signal) upon 
treatment with the PKC inhibitor Gö6976 or PKC immunodepletion prior to infection. As 
with any protein present in the erythrocyte cytoplasm, a significant amount of CKAR was 
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taken up into the parasite digestive vacuole, causing an intense CKAR FRET signal 
within this organelle likely due to intermolecular FRET. In order to account for this artifact 
in our measurements of host PKC activity, 3D7-CKAR parasites were removed from 
their host cells and intracellular FRET signal was quantified to assess this background 
signal within the digestive vacuole (Figure 12C). By FRET microscopy (Figure 11B) and 
background-corrected fluorometry to remove digestive vacuole signal (Figure 11C), we 
show limited host PKC activity throughout the ring and trophozoite stages (0-25 hpi) with 
a sharp increase during schizogony (30-40 hpi). Immunodepletion of Gαq or PLCβ1 
ablates PKC activity during the entire infectious cycle, reinforcing the importance of the 
host Gαq signaling pathway upstream of PKC activation (Figure 12D). PMA restored 
PKC activity in these parasite-infected erythrocytes depleted of signaling components 
and also rescued the associated exit defect (Figure 12E), further indicating a critical role 
for host PKC. PKC activity reporter cell lines were also generated via stable expression 
of CKAR in U2OS host cells prior to T. gondii infection. The CKAR signal output 
throughout the T. gondii life cycle in these reporter U2OS cells largely mirrored the 
results obtained in P. falciparum, with maximal FRET signal occurring in the last third of 
the intracellular life cycle (Figure 11D-F). Knockdown of host gnaq or plcb1/plcg1 
ablates PKC activity but this activity was restored by the PKC agonist PMA (Figure 
11H,I). 
In a previous chapter, we have shown that the host cytoskeletal protein adducin is 
lost from the erythrocyte actin cytoskeleton at ~35 hpi of P. falciparum in a calpain-
independent manner (Millholland et al., 2011). As adducin cytoskeletal association is 
regulated by the PKC-mediated phosphorylation of residues S716/S726 (Matsuoka et 
al., 1996), we assessed PKC depletion on host adducin cytoskeletal association during 
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parasite infection. Western blot and immunofluorescence analysis of host cytoskeletal 
fractions confirms adducin disappearance from both P. falciparum-infected erythrocytes 
(Figure 11G, top; Figure 12F) and T. gondii-infected U2OS cells late in the intracellular 
cycle (Figure 11H, top; Figure 12G). However, PKCα/β immunodepletion from 
erythrocytes (Figure 11G, bottom) or shRNA knockdown in U2OS cells (Figure 11H, 
bottom) abrogates this loss and maintains adducin cytoskeletal association through the 
end of both parasite life cycles. The S716/S726 phosphorylated adducin species (p-
adducin) accumulates in mock-treated cells in the last third of the life cycle by western 
blot while the unphosphorylated form is lost from cytoskeletal fractions, unless PKCα/β is 
depleted from host cells. Gαq or PLCβ1 immunodepletion from erythrocytes (Figure 
12F), or knockdown in U2OS cells (Figure 12G) also caused adducin persistence within 
the host cytoskeleton, highlighting the function of this upstream cascade. 
In order to examine the effect of adducin persistence on T. gondii life cycle 
progression, we overexpressed the PKC phospho-mutant adducin (S716A/S726A; 
(Matsuoka et al., 1998) as well as wild-type adducin in host A549 cells. S716A/S726A 
adducin expression resulted in minimal phosphorylation by western blot upon T. gondii 
infection (Figure 11I), while wild-type adducin overexpressors show an abundance of p-
adducin. Similar to PKCα/β stable knockdown, S716A/S726A adducin expression 
resulted in the persistence of enlarged vacuoles by 60 hpi (Figure 11J,K), with no effect 
on parasite replication (Figure 11L), suggesting that PKC-induced adducin loss directly 
mediates host cell cytolysis. Tachyzoites trapped within host cells show reduced viability 
following 18-24 hours of blocked cytolysis within host cells expressing the adducin 
phospho-mutant S716A/S726A, similar to PKC inhibition or knockdown (Figure 12B), 
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highlighting the feasibility of targeting this phase of the parasite life cycle as an 
antiparasitic strategy. 
Host signaling cascade is required for calpain-mediated cytoskeletal proteolysis 
 Host calpain activation has been shown to result in cytoskeletal proteolysis 
necessary for parasite exit (Chandramohanadas et al., 2009; Millholland et al., 2011). 
We thus assessed calpain activation following immunodepletion of signaling components 
from erythrocytes using an activity-based probe for cysteine proteases, DCG04  (Figure 
13A; (Greenbaum et al., 2000). As opposed to negative control PKAα/β 
immunodepleted cells which show a clear active calpain band at the conclusion of the 
life cycle, PKCα/β, PLCβ1, and Gαq immunodepletion disallows calpain activation, 
similar to calpain immunodepleted cells. CaM-1 immunodepletion resulted in diminished 
calpain activation, indicating that CaM-1 may facilitate this process. As a corollary to 
calpain activation, we examined spectrin cleavage via western blot, a key calpain 
substrate. Immunodepletion of pathway components abrogates spectrin proteolysis in P. 
falciparum-infected erythrocytes at 50 hpi, while PKAα/β-immunodepleted cells show 
multiple spectrin fragments (Figure 13B). Interestingly, in vitro incubation of U2OS cell 
membrane fractions with activated CaMKII prior to incubation with calpain resulted in 
multiple spectrin cleavage products (Figure 13C), suggesting that CaMKII 
phosphorylation of cytoskeletal substrates may enhance calpain-mediated proteolysis. 
CaMKII activation is shown by CaM-1 co-immunoprecipitation and autophosphorylation 
by p-CaMKII western blot analysis near the end of the T. gondii life cycle (Figure 13D), 
suggesting that host CaMKII activity may enhance cytoskeletal proteolysis to facilitate 
parasite release. 
Analysis of host Ca2+ dynamics Implicates TRPC6 in Ca2+ influx  
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Finally, we determined changes in host [Ca2+] that drive this network. To assess 
erythrocyte [Ca2+] during P. falciparum infection, we confined a Ca2+ indicator to the 
erythrocyte space via loading of a fura-2-dextran conjugate. Within the U2OS cell 
cytoplasm during T. gondii infection, Ca2+ measurements were achieved via expression 
of the ratiometric FRET-based Ca2+ indicator yellow cameleon 3.6  (YC3.6) in U2OS 
cells (Nagai et al., 2004; Palmer and Tsien, 2006). By microscopy and background-
corrected fluorometry (Figure 14A,B), we show the relative changes in host cell [Ca2+] to 
be similar between both parasite systems, with host [Ca2+] hovering near resting levels 
(100 nM) throughout the first two-thirds of the life cycle, followed by a sharp increase in 
[Ca2+] at the point of parasite release. 
Given the large [Ca2+] increase seen in both T. gondii and P. falciparum host cells, 
we further hypothesized that host plasma membrane cation channels play a role in this 
influx. siRNA-mediated knockdown studies of mechanosensitive transient receptor 
potential (TRP) channels (trpc1, trpc3, trpc6) as well as canonical endoplasmic reticulum 
Ca2+ channels (ryr3, ip3r1) identified TRPC6 as a specific mediator of T. gondii exit, as 
trpc6 knockdown resulted in an accumulation of unruptured vacuoles by 60 hpi (p<0.05; 
Figure 14C,D). Trpc6 knockdown using multiple siRNA oligos abrogated the large 
increase in cytoplasmic [Ca2+] while ip3r1 knockdown diminished the initial minor 
increase in [Ca2+] observed earlier in T. gondii infection, indicating that PLC activity and 
generation of IP3 may be responsible for the minor increase in [Ca2+] seen only in T. 
gondii-infected cells (Figure 14E). 
Pharmacological studies in P. falciparum-infected erythrocytes confirmed the 
importance of mechanosensitive cation channel function in parasite-mediated cytolysis 
(Figure 15A). [Ca2+] diminished in cells depleted of Gαq, PLCβ, or PKCα/β (Figure 
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15B,C), but was rescued by PKC activation with PMA in cells depleted of Gαq or PLCβ, 
indicating that PKC activity facilitates later Ca2+ influx, perhaps via adducing 
phosphorylation and loss. PMA could not rescue Ca2+ influx in cells depleted of PKCα/β, 
further confirming the necessity of PKC activity for this process. Taken together, these 
data highlight the importance of TRPC6-mediated cation influx in host cell cytolysis, 
perhaps as a mechanosensitive response to cytoskeletal rearrangement. 
Mammalian PKC inhibitor demonstrates anti-parasitic activity in vivo 
In order to assess the importance of this signaling cascade in parasitic disease 
progression, we endeavored to test inhibition of this cascade on parasite burden in vivo. 
Given that PKC has been targeted for drug development efforts in multiple disease 
contexts from cancer to transplant rejection, and there are no known orthologs of the 
classical PKC enzymes in apicomplexan genomes, we undertook studies of known PKC 
inhibitors in murine models of malaria and toxoplasmosis. Intravenous injection of 10 
mg/kg Gö6976, an inhibitor of classical mammalian PKC enzymes, caused a significant 
decrease in parasitemia in a mouse P. yoelii malaria model in the classic 4-day Peter’s 
suppression test (Figure 16A). Similarly, intraperitoneal injection of 10 mg/kg Gö6976 
limited T. gondii parasite burden in both the spleen (p<0.0001; Figure 16B, top) and 
peritoneal exudate cells (p<0.0001; Figure 16B, bottom). The consistency in 
antiparasitic activity in vivo further suggests the importance of host PKC function in both 
parasitic infections and underscores the conserved function of this host-signaling 
pathway. 
As further corroboration of the central role of host PKC in severe malaria, we 
undertook studies of the orally-bioavailable specific PKC inhibitor sotrastaurin in a 
mouse model of experimental cerebral malaria (Figure 16C,D). This inhibitor has 
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passed Phase I trials and is undergoing Phase II trials for numerous indications (Budde 
et al., 2010; Friman et al., 2011; Wagner et al., 2009), underscoring its potential as an 
antimalarial drug candidate. 50 mg/kg by gastric gavage in a standard 4-day Peters’ 
suppression test led to a significant decrease in P. berghei ANKA parasitemia 
(p<0.0001; Figure 16C) and significantly increased survival versus vehicle-treated 
controls (p=0.0029; Figure 16D). We show direct translation of biological discovery to 
therapeutic design: identification of this host signaling activity translates directly to a drug 
discovery effort, as known inhibitors of extensively-studied host PKC enzymes control 
parasitic disease in vivo. Given the multitude of other active proteins within the cascade, 
it is clear that these newly identified host mediators of parasite-induced cytolysis 
represent an untapped resource of antiparasitic targets.  
TCA metabolites may initiate the cytolytic cascade through interaction with 
Gαq-coupled GPCRs 
As Gαq, PLC, and PKC converge in established GPCR signaling networks, we 
hypothesized that GPCRs may play a role in initiation of this host pathway. Considering 
that parasites do not encode GPCRs, we suggest a parasite-derived small molecule 
ligand may signal to GPCRs of host origin through direct interaction with the host cell 
membrane to mediate signaling through Gαq. We found it striking that several parasite 
metabolites peak during schizogony, especially the TCA cycle intermediate 
alphaketoglutarate (αKG; (Olszewski et al., 2009). As αKG and other TCA cycle 
intermediates including succinate have recently been shown to signal through Gαq-
coupled GPCRs, such as oxoglutarate receptor 1 (oxgr1) and succinate receptor 1 
(sucnr1; (He et al., 2004; Qi et al., 2004), we hypothesized that increased parasite 
metabolism during periods of high replication may initiate host cell signaling leading to 
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cytolysis. To test this idea, we first confirmed by western blot analysis that OXGR1 and 
SUCNR1 were found in erythrocytes (Figure 17A) and U2OS cells (Figure 17B) and not 
in parasites. Immunofluorescence studies of both GPCRs revealed puncta on the host 
plasma membrane in uninfected and infected cells; however, there was a surprising 
enrichment on the PV membrane in both P. falciparum-infected erythrocytes and T. 
gondii-infected U2OS cells. To test whether these host GPCRs play a role in the 
signaling cascade, we undertook knockdown studies of metabolite-sensing GPCRs in 
U2OS cells and assayed for delays in T. gondii-mediated cytolysis. Simultaneous 
knockdown of oxgr1 and sucnr1 caused an accumulation of large PVs at 60 hpi (p<0.09) 
versus negative control cells or knockdown of the Gαi–coupled lactate receptor gpr81, in 
which cytolysis occurred by 52 hpi (Figure 17C, D). 
To further validate the knockdown results, we assessed whether activation of 
these host GPCRs occurs prior to parasite exit. To do this, we utilized commercially 
available Chem-1 cell lines (Millipore) that allow direct measurement of specific GPCR 
activity through overexpression of Gαq and only OXGR1 or SUCNR1, on a parent cell 
line background which expresses few endogenous GPCRs. T. gondii infection of Chem-
1 cells overexpressing either OXGR1 or SUCNR1 showed GPCR activity (as measured 
by Fluo-8 fluorescence) to persist during the last third of the parasite life cycle until 
cytolysis (Figure 17E, F). Conversely, the parental Chem-1 cell line displayed limited 
GPCR activity throughout the T. gondii life cycle and a significant delay in parasite-
mediated cytolysis (Figure 17G), further suggesting a role for metabolite-sensing 
GPCRs. Satisfyingly, a mixture of exogenous αKG/succinate initiated a hastening of T. 
gondii exit, occurring ~20 hours sooner than incubation with DMSO alone or lactate 
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(Figure 17H). Furthermore, αKG/succinate induced premature lysis of P. falciparum 
parasites leading to parasite death (Figure 17I). 
Discussion 
Host cell cytolysis was thought to be largely parasite-mediated, mainly due to 
increasing pressure on the host cell membrane and cytoskeleton by the growing parasite 
body (Glushakova et al., 2010; Glushakova et al., 2005). However, we have recently 
shown that host calpain-mediated proteolysis of host cytoskeletal proteins is necessary 
for parasite exit (Chandramohanadas et al., 2009; Millholland et al., 2011). In this work 
we present a complex host-derived signaling pathway that functions in parasite-
mediated cytolysis, suggesting that host cell cytolysis is a highly regulated process 
requiring a complex interplay of host-derived components. 
We present a model (Figure 18) in which diffusion of parasite-derived small 
molecule GPCR ligands outside into the PV space and host cell results in 
overstimulation of host GPCRs. These GPCRs engage a Gαq-mediated signaling 
pathway converging on PKC activation that results in the complete loss of a key 
cytoskeletal component, and leads to pathological Ca2+ influx through mechanosensitive 
plasma membrane TRP channels. Ca2+-charged host CaM activates CaMK which in turn  
phosphorylates cytoskeletal substrates, increasing their propensity for calpain-mediated 
proteolysis. Increasing cytoplasmic [Ca2+] induces global calpain activation which results 
in the proteolysis of various substrates, and in turn causes the loss of host cell plasma 
membrane integrity to allow for parasite release. 
PKC and calpain play key roles within this cascade, a partnership that has been 
underscored in other human pathologies related to GPCR overstimulation, including 
glutamate neuroexcitotoxicity and post-myocardial infarction cell death. PKC 
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downregulation has been shown to protect against glutamate neurotoxicity (Ahlemeyer 
et al., 2002; Favaron et al., 1990; Hasham et al., 1997), while calpain inhibition has been 
shown to abrogate neuronal cell death (Witt et al., 1994) and block Ca2+ influx (Weiss et 
al., 1990). Similarly, PKC and calpain are thought to play a role in post-myocardial 
infarction ischemic cell death of multiple tissues (Bright et al., 2004; Padanilam, 2001; 
Piccoletti et al., 1992; Speechly-Dick et al., 1994) as inhibitors of these enzymes offer 
protective effects (Bevers et al., 2010; Bevers et al., 2009; Koponen et al., 2003; Neuhof 
et al., 2008; Wagey et al., 2001; Wei et al., 2010). Though it is unclear whether the 
sequential activation of these enzymes is necessary for cell death in these disease 
contexts, we suggest that PKC activity is an essential upstream component of 
pathological calpain activation in the context of parasite infection. Given the antiparasitic 
activity of PKC inhibitors in mouse models of both toxoplasmosis and malaria, inhibition 
of multiple host proteins upstream of PKC activity will likely limit parasite growth with low 
propensity for generation of resistance in the field. 
	  
 
 
	  
 
 
 
 
 
 
Table 3. siRNA screen in U2OS cells Identifies Host Mediators of T. gondii-Induced Host Cell Cytolysis 
SINGLE GENES 
Means shown are representative of at least 3 separate experiments.  N=3. 
Gene 
Symbol Full Gene Name 
Unruptured 
Vacuoles/ 
Field          
(44 hpi) 
SEM  
(44 hpi) 
Unruptured 
Vacuoles/ 
Field           
(60 hpi) 
SEM   
(60 hpi) GO Term 
LEGEND: NEGATIVE CONTROL           
  POSITIVE CONTROL        
  POSITIVE HIT           
anxa1 annexin A1 1.53 0.244 0.0427 0.0295 
calcium ion binding, calcium-
dependent phospholipid binding, 
phospholipase inhibitor activity 
anxa2 annexin A2 1.07 0.332 0.0632 0.0552 
calcium ion binding, calcium-
dependent phospholipid binding, 
phospholipase inhibitor activity 
cytoskeletal protein binding 
atp2a3 ATPase, Ca++ transporting, ubiquitous 1.74 0.188 0.0222 0.0329 
calcium ion transport, cation 
transport 
atp8b1 ATPase, aminophospholipid transporter, class I, type 8B, member  1.432 0.182 0.0341 0.0328 
ion transmembrane transport, 
phospholipid transport, membrane 
fraction 
cabin1 calcineurin binding protein 1 1.69 0.152 0.0281 0.0388 cell surface receptor linked signaling pathway 
calcr calcitonin receptor 1.14 0.127 0.0733 0.0621 
plasma membrane, G-protein 
signaling, coupled to cAMP 
nucleotide second messenger 
calm1 Calmodulin 1   1.94 0.159 0.147 0.0913 calcium ion binding, calcium-dependent protein binding 
calm2 Calmodulin 2 1.32 0.273 0.0986 0.0325 calcium ion binding, calcium-dependent protein binding 
camk1 calcium/calmodulin-dependent protein kinase I 1.09 0.299 0.114 0.0374 signal transduction 
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camk2a calcium/calmodulin-dependent protein kinase II alpha 1.53 0.263 0.195 0.0522 
calcium- and calmodulin-dependent 
protein kinase complex; calmodulin 
binding 
camk2b calcium/calmodulin-dependent protein kinase II beta 0.978 0.264 0.166 0.0426 
calcium ion binding, calmodulin 
binding 
capn1 calpain 1, (mu/I) large subunit 1.42 0.283 0.522 0.0893 
calcium ion binding, calcium-
dependent cysteine-type 
endopeptidase activity 
capn2 calpain 2, (m/II) large subunit 1.19 0.174 0.476 0.0783 
calcium ion binding, calcium-
dependent cysteine-type 
endopeptidase activity 
capn5 calpain 5 1.57 0.293 0.156 0.108 
signal transduction, calcium-
dependent cysteine-type 
endopeptidase activity 
capns1 calpain, small subunit 1 1.21 0.273 1.21 0.214 
calcium ion binding, calcium-
dependent cysteine-type 
endopeptidase activity 
gnaq guanine nucleotide binding protein (G protein), q polypeptide 1.48 0.284 1.08 0.412 
G-protein coupled receptor protein 
signaling pathway; signal transducer 
activity 
gnai1 
Guanine nucleotide binding protein 
(G protein), alpha inhibiting activity 
polypeptide 1 
1.324 0.236 0.135 0.0316 
G-protein coupled receptor protein 
signaling pathway; signal transducer 
activity 
gnai2 
Guanine nucleotide binding protein 
(G protein), alpha inhibiting activity 
polypeptide 2 
1.24 0.331 0.0598 0.0566 
G-protein coupled receptor protein 
signaling pathway; signal transducer 
activity 
gnai3 
Guanine nucleotide binding protein 
(G protein), alpha inhibiting activity 
polypeptide 3 
1.05 0.364 0.214 0.0523 
G-protein coupled receptor protein 
signaling pathway; signal transducer 
activity 
gnas guanine nucleotide binding protein (G protein), alpha s 1.34 0.236 0.172 0.0615 
G-protein coupled receptor protein 
signaling pathway; signal transducer 
activity 
gna12 guanine nucleotide binding protein (G protein), alpha 12 1.77 0.164 0.118 0.0427 
G-protein coupled receptor protein 
signaling pathway; signal transducer 
activity 
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gna13 guanine nucleotide binding protein (G protein), alpha 13 0.96 0.234 0.0464 0.0634 
G-protein coupled receptor protein 
signaling pathway; signal transducer 
activity 
kcnn4 
potassium intermediate/small 
conductance calcium-activated 
channel, subfamily N, member 4 
1.24 0.236 0.1953 0.0597 
plasma membrane, ion transport, 
calcium-activated potassium channel 
activity 
lmna lamin A/C 1.05 0.235 0.1655 0.0693 intermediate filament, structural molecule activity 
mylk myosin light chain kinase 1.09 0.296 0.112 0.0882 kinase activity 
pik3ca phosphoinositide-3-kinase, catalytic, alpha polypeptide 1.69 0.253 0.0821 0.0333 signal transduction 
pik3cb phosphoinositide-3-kinase, catalytic, beta polypeptide 1.32 0.128 0.184 0.0413 signal transduction 
pla2g4a phospholipase A2, group IVA 1.22 0.237 0.142 0.0894 calcium ion binding; calcium-dependent phospholipase A2 activity 
plcb1 phospholipase C, beta 1  1.65 0.385 0.121 0.0521 calcium ion binding, signal transduction 
plcb2 phospholipase C, beta 2 1.21 0.236 0.0541 0.0433 calcium ion binding, signal transduction 
plcb3 phospholipase C, beta 3  1.55 0.237 0.112 0.0323 calcium ion binding, signal transduction 
plcd1 phospholipase C, delta 1 1.26 0.235 0.184 0.0166 calcium ion binding, signal transduction 
plcg2 phospholipase C, gamma 2 1.34 0.384 0.193 0.0882 
signal transduction, activation of 
store-operated calcium channel 
activity 
plcg1 phospholipase C, gamma 1 1.31 0.254 0.113 0.063 calcium ion binding, signal transduction 
plscr1 phospholipid scramblase 1 1.47 0.295 0.144 0.0511 calcium ion binding, plasma membrane 
prkaca protein kinase, cAMP-dependent, catalytic, alpha 1.01 0.133 0.125 0.0417 
plasma membrane, cAMP-
dependent protein kinase inhibitor 
activity 
prkacb protein kinase, cAMP-dependent, catalytic, beta 1.08 0.188 0.214 0.135 
signal transduction, plasma 
membrane 
prkca protein kinase C, alpha 0.953 0.213 0.242 0.0335 signal transduction, plasma membrane 
prkcb protein kinase C, beta 1.09 0.223 0.0842 0.0446 signal transduction, plasma 
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membrane 
prkcg protein kinase C, gamma 1.04 0.192 0.0655 0.0875 signal transduction 
ppp3ca protein phosphatase 3, catalytic subunit, alpha isozyme 1.44 0.214 0.0541 0.114 calcium ion transport 
ptk2 PTK2 protein tyrosine kinase 2 0.874 0.122 0.177 0.0552 cytoskeleton, plasma membrane 
rac1 
ras-related C3 botulinum toxin 
substrate 1 (rho family, small GTP 
binding protein Rac1) 
1.41 0.216 0.0842 0.0224 plasma membrane, signal transduction 
rac2 
ras-related C3 botulinum toxin 
substrate 2 (rho family, small GTP 
binding protein Rac2) 
1.21 0.177 0.0831 0.0452 plasma membrane, signal transduction 
rhoa ras homolog gene family, member A 0.915 0.131 0.113 0.0316 plasma membrane, cytoskeleton, signal transduction 
rhob ras homolog gene family, member B 0.889 0.122 0.145 0.0332 plasma membrane, signal transduction 
Scr scrambled oligo (negative control) 1.21 0.112 0.0731 0.0221   !!!!!!!!!!!!!!!!!!!!!!
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Table 4. MULTI-ISOFORM FAMILIES AND CONSTITUENTS 
Means shown are representative of 3 separate experiments.  N=3. 
Gene Family Single Genes Included Unruptured Vacuoles/ Field (44 hpi) SEM (44 hpi) 
Unruptured Vacuoles/ 
Field (60 hpi) SEM (60 hpi) 
LEGEND: NEGATIVE CONTROL         
  POSITIVE CONTROL       
  POSITIVE HIT         
Annexin 
anxa1 
1.19 0.311 0.0594 0.0442 
anxa2 
            
Calmodulin 
(CaM) 
calm1 
0.974 0.223 0.713 0.195 
calm2 
            
CaM Kinase 
camk1 
1.07 0.142 0.822 0.138 camk2a 
camk2b 
            
Calpain 
capn1 
1.17 0.281 0.973 0.155 capn2 
capns1 
            
G-alpha 
subunits 
gnaq 
1.11 0.262 0.842 0.155 
gnai1 
gnai2 
gnai3 
gnas 
gna12 
gna13 
            
Lamin 
lmna 
1.24 0.171 0.121 0.0997 lmnb1 
lmnb2 
63
            
PI3-Kinase 
pik3ca 
0.892 0.174 0.112 0.164 
pik3cb 
            
Phospholipase 
C 
plcb1 
1.22 0.242 0.942 0.232 
plcb2 
plcb3 
plcd1 
plcg2 
plcg1 
            
Protein Kinase 
C 
prkca 
1.41 0.331 0.914 0.176 prkcb 
prkcg 
            
Rac GTPases 
rac1 
1.09 0.132 0.141 0.0571 
rac2 
            
Rho GTPases 
rhoa 
1.11 0.233 0.0912 0.0778 
rhob !!!!!!!!!!!!!!!!
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Table 5. GENE PAIRS 
Means shown are representative of 5 separate experiments.  N=5. 
Gene (s) Unruptured Vacuoles/Field SEM  Unruptured Vacuoles/Field SEM  
(44 hpi) (44 hpi) (60 hpi) (60 hpi) 
LEGEND: NEGATIVE CONTROL       
  POSITIVE CONTROL   
 
  
  POSITIVE HIT       
Scr #1 1.53 0.244 0.233 0.071 
Scr #2 1.07 0.332 0.103 0.099 
capn1 #1 1.21 0.212 0.312 0.041 
capn1 #2 1.33 0.155 0.441 0.198 
capn2 #1 1.13 0.213 0.291 0.171 
capn2 #2 1.17 0.199 0.212 0.104 
capn1 #1/capn2 #1 1.22 0.273 1.31 0.285 
capn1 #2/capn2 #2 1.41 0.112 1.05 0.256 
capns1 #1 1.74 0.188 1.83 0.265 
capns1 #2 1.432 0.182 1.91 0.228 
calm1 #1 1.69 0.152 0.243 0.243 
calm1 #2 1.14 0.127 0.0166 0.0166 
calm2 #1 1.33 0.166 0.132 0.078 
calm2 #2 1.22 0.183 0.0664 0.015 
calm1 #1/calm2 #1 1.44 0.151 1.06 0.311 
calm1 #2/calm2 #2 1.32 0.273 1.09 0.416 
camk1 #1 1.09 0.299 0.203 0.145 
camk1 #2 1.53 0.263 0.206 0.118 
camk2a #1 0.97 0.264 0.252 0.284 
camk2a #2 1.42 0.283 0.241 0.144 
camk2b #1 1.39 0.211 0.311 0.188 
camk2b #2 1.44 0.24 0.16 0.0981 
camk1 #1/camk2a #1 1.89 0.174 1.02 0.204 
camk1 #2 /camk2a #2 1.57 0.293 1.18 0.393 
65
camk1 #1/camk2b #1 1.41 0.31 0.033 0.0242 
camk1 #2/camk2b #2 1.29 0.283 0.17 0.0886 
camk2a #1/camk2b 
#1 1.33 
0.137 0.41 0.283 
camk2a #2/camk2b 
#2 1.11 
0.152 0.22 0.144 
gnaq #1 1.2 0.273 0.751 0.22 
gnaq #2 1.48 0.284 0.983 0.245 
prkaca #1 1.223 0.236 0.203 0.306 
prkacb #2 1.24 0.331 0.4 0.173 
prkaca #1 1.05 0.364 0.133 0.0881 
prkacb #2 1.94 0.236 0.13 0.0458 
prkaca #1 /prkacb #1 1.77 0.164 0.116 0.0617 
prkaca #2/prkacb #2 0.96 0.234 0.08 0.0404 
prkca #1 1.24 0.236 0.0633 0.0633 
prkca #2 1.05 0.231 0.113 0.094 
prkcb #1 1.09 0.296 0.176 0.092 
prkcb #2 1.34 0.369 0.08 0.0416 
prkca #1/prkcb #1 1.69 0.253 0.943 0.233 
prkca #2/prkcb #2 1.12 0.129 0.776 0.174 
prkca #1/prkcg #1 1.53 0.244 0.18 0.126 
prkca #2/prkcg #2 1.33 0.332 0.233 0.233 
prkcb #1/prkcg #1 1.07 0.188 0.103 0.103 
prkcb #2/prkcg #2 1.06 0.243 0.183 0.0652 
plcb1 #1 1.4 0.238 0.11 0.104 
plcb1 #2 1.6 0.385 0.176 0.0766 
plcd1 #1 1.04 0.211 0.213 0.0551 
plcd1 #2 1.13 0.283 0.118 0.0413 
plcg1 #1 1.2 0.236 0.044 0.08 
plcg1 #2 1.75 0.237 0.113 0.0133 
plcb1 #1/plcg1 #1 1.26 0.235 0.733 0.375 
plcb1 #2/plcg1 #2 1.14 0.384 0.693 0.196 
66
plcb1 #1/ plcd1 #1 1.41 0.112 0.179 0.0551 
plcb1 #2/plcd1 #2 1.67 0.295 0.143 0.0523 
plcd1 #1/plcg1 #1 1.22 0.263 0.177 0.0989 
plcd1 #2/plcg1 #2 1.31 0.254 0.136 0.0491 !
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Figure 7: siRNA screen identifies novel signaling components 
required for T. gondii-mediated cytolysis. (A, B) 
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Figure 7: siRNA screen identifies novel signaling components 
required for T. gondii-mediated cytolysis. (C-E) 
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 Figure 7: siRNA screen identifies novel signaling components 
required for T. gondii-mediated cytolysis. (F, G) 
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Figure 8. Design of siRNA screen to identify host genes required for 
T. gondii-mediated cytolysis. 
 
For the primary screen, pooled siRNAs targeting a select set of 50 genes and 8 multiple gene families (three 
siRNAs/gene) were arrayed in collagen-coated 96-well plates (in quadruplicate), reverse-transfected into 
U2OS cells.  Following synchronous T. gondii infection at 24 hours post-transfection, plates were fixed and 
imaged by fluorescence microscopy at 6, 24, 44 or 60 hpi. Image analysis was used to calculate parasite 
doublings as a measure of parasite replication and parasites per PV to assess progression of the entire 
intracellular parasite life cycle including cytolysis. Hits were selected based on persistence of large vacuoles 
at 60 hpi.  The secondary screen included 19 individual genes and degenerate pairs of the multiple gene 
family hits, for a total of 17 multiple gene knockdowns using multiple oligos for validation.  Hits from the 
secondary screen (individual genes or gene pairs) were tested in the final screen in 24-well plates. 
Images/western blots of stable shRNA knockdown cells were utilized in Figure 7F,G. 
 
 
 
 
 
 
 
 
 
	  
	  
72	  
Figure 9:  Conserved function of host proteins in P. falciparum-
mediated cytolysis. (A, B) 
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Figure 9:  Conserved function of host proteins in P. falciparum-
mediated cytolysis. (C, D) 
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Figure 10.  Depletion of PLCβ1 and calmodulin-1 from erythrocytes is 
sufficient to block P. falciparum-mediated cytolysis. 
 
(A). Erythrocytes depleted of either PLCβ1, PLCγ, or both PLCβ1 and PLCγ were assayed for schizont 
persistence (left panel) or reinvasion of new rings (right panel) at 60 hpi.  Though PLCβ1 depletion caused a 
significant persistence of schizont stage parasites and a reciprocal decrease in newly reinvaded rings 
(*p<0.05), indicating a block in cytolysis, PLCγ depletion did not alter normal life cycle progression.  Dual 
depletion of both PLCβ1 and PLCγ did not significantly exaggerate the block in cytolysis from PLCβ1 alone, 
indicating that PLCγ does not have a significant role in this process. Data shown are means of at least 3 
experiments +/- SEM; n=3. (B). Erythrocytes depleted of either calmodulin-1, calmodulin-2, or both 
calmodulin-1 and calmodulin-2 were assayed for schizont persistence (left panel) or reinvasion of new rings 
(right panel) at 60 hpi.  Though calmodulin-1 depletion caused a significant persistence of schizont stage 
parasites and a reciprocal decrease in newly reinvaded rings, indicating a block in cytolysis (*p<0.05), 
calmodulin-2 depletion did not alter normal life cycle progression.  Dual depletion of both calmodulin-1 and 
calmodulin-2 did not significantly exaggerate the block in cytolysis from calmodulin-1 alone, indicating that 
calmodulin-2 does not have a significant role in this process.  Data shown are means of at least three 
experiments +/- SEM; n=3. 
 
	  
	  
75	  
 
Figure 11: Host PKC is activated late in the parasite intracellular cycle 
and abrogates host adducin cytoskeletal association. (A-C) 
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 Figure 11: Host PKC is activated late in the parasite intracellular 
cycle and abrogates host adducin cytoskeletal association. (D-F) 
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Figure 11: Host PKC is activated late in the parasite intracellular cycle 
and abrogates host adducin cytoskeletal association. (G, H) 
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Figure 11: Host PKC is activated late in the parasite intracellular cycle 
and abrogates host adducin cytoskeletal association. (I-L) 
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Figure 12. Host Gαq and PLCβ1/γ1 are required upstream for host 
PKCα/β function in adducin loss prior to parasite-mediated cytolysis.  
(A, B) 
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Figure 12. Host Gαq and PLCβ1/γ1 are required upstream for host 
PKCα/β function in adducin loss prior to parasite-mediated cytolysis.  
(C-E) 
 
 
(C). 3D7-CKAR parasites removed from their host cells via saponin treatment were assessed for 
CKAR fluorescence to account for digestive vacuole uptake.  Representative 30-hour image (left) and 
population-based fluorometry throughout the life cycle (right) show digestive vacuole fluorescence, 
which is removed as background from all 3D7-CKAR measurements in Figure 12. Data shown are 
means of at least three experiments +/- SEM; n=4. (D). 3D7-CKAR fluorescence at 35 hpi following 
immunodepletion of key host signaling components. Representative images show that Gαq and 
PLCβ1 immunodepletion diminished CKAR signal in the host cell compartment, which was rescued 
by 100 nM PMA. Data shown are means of at least three experiments +/- SEM. (E). Erythrocyte 
CKAR FRET-based fluorescence of 3D7-CKAR parasites and life cycle progression as measured by 
quantitation of ring stage parasites at 60 hpi following depletion of Gαq or PLCβ1. Data shown are 
means of at least three experiments +/- SEM 
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Figure 12. Host Gαq and PLCβ1/γ1 are required upstream for host 
PKCα/β function in adducin loss prior to parasite-mediated cytolysis.  
(F,G) 
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Figure 12. Host Gαq and PLCβ1/γ1 are required upstream for host 
PKCα/β function in adducin loss prior to parasite-mediated cytolysis.  
(H,I) 
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Figure 13: Host signaling cascade enhances calpain-mediated 
cytoskeletal proteolysis just prior to parasite exit. 
 
 (A). DCG04-labeling of active calpain in P. falciparum-infected erythrocyte fractions at 50 hpi in cells 
depleted of Gαq, PLCβ1, PKCα/β, and CaM-1 by immunodepletion. Biotin blot confirms calpain activity upon 
labeling. Negative control: Calpain-1 depletion; positive control: PKAα/β depletion; loading control: actin. (B). 
α−Spectrin cleavage by western blot at 50 hpi in erythrocyte cytoskeletal fractions following depletion of 
signaling components. (C). α−Spectrin cleavage by western blot following in vitro incubation of U2OS cell 
cytoskeletal fractions with activated CaMKII prior to incubation with recombinant human calpain-1. (D). Host 
CAMKII/calmodulin-1 coimmunoprecipitation through the T. gondii life cycle and presence of p-CAMKII (the 
activated form) by western blot. 
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Figure 14: Host [Ca2+] increases throughout the last third of the 
intracellular cycle, in a TRPC6-dependent manner. (A) 
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Figure 14: Host [Ca2+] increases throughout the last third of the 
intracellular cycle, in a TRPC6-dependent manner. (B) 
 
 
 
 
 
(B
). 
R
ep
re
se
nt
at
iv
e 
im
ag
es
 o
f 
T.
 g
on
di
i-i
nf
ec
te
d 
U
2O
S
 c
el
ls
 e
xp
re
ss
in
g 
Y
C
3.
6 
(le
ft)
. 
[C
a2
+ ]
 a
s 
a 
fu
nc
tio
n 
of
 C
FP
/Y
FP
 
FR
E
T 
(r
ig
ht
). 
D
at
a 
sh
ow
n 
ar
e 
m
ea
n 
C
a2
+  
m
ea
su
re
m
en
ts
 o
f a
t l
ea
st
 th
re
e 
ex
pe
rim
en
ts
 ±
 S
E
M
.  
	  
	  
86	  
Figure 14: Host [Ca2+] increases throughout the last third of the 
intracellular cycle, in a TRPC6-dependent manner. (C,D) 
 
 
 
 
 
 
 
 
 
 
 
(C) Representative images and quantitation (D) at 44 and 60 hpi of siRNA-mediated knockdown of 
cation channels prior to T. gondii infection. Positive control: Capns1; negative control: scr oligo. Data 
shown are mean unruptured vacuoles per field ± SEM (*p<0.05; **p<0.01).  
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Figure 14: Host [Ca2+] increases throughout the last third of the 
intracellular cycle, in a TRPC6-dependent manner. (E) 
 
 
 
(E). Representative images (left) and [Ca2+] measurements as a function of CFP/YFP FRET (right) at 5 T. 
gondii divisions (~35 hpi) following siRNA-mediated knockdown of cation channels in U2OS cells expressing 
YC3.6. Data shown are mean Ca2+ measurements ± SEM.  
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Figure 15.  PKC activity, as mediated by Gαq and PLC, is required for 
Ca2+ influx at the end of the parasite life cycle. (A, B) 
 
 
 
 
A).  Giemsa images at specified timepoints following treatment beginning at 30 hpi with 500 nM cation 
channel inhibitors GsTMx-4, 2-APB, SKF-63563, or Pyr3. (B). Population level measurement of schizont 
persistence (left) and new ring formation (right) following inhibition of cation channel inhibitors at 30 hpi. 
Data shown are means of at least three experiments +/- SEM; *p<0.05; **p<0.01.  
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Figure 15. PKC activity, as mediated by Gαq and PLC, is required for 
Ca2+ influx at the end of the parasite life cycle. (C) 
  
 
 
 
 
(C). Representative FRET images and population level fluorometry at 5 T. gondii parasite divisions of U2OS 
cells expressing YC3.6 following knockdown of gnaq, plcb1/plcg1, or prkca/prkcb show that [Ca2+] is limited 
upon knockdown of these signaling members.  100 nM PMA treatment rescues Ca2+ influx following gnaq or 
plcb1/plcg1 knockdown, though it cannot be rescued following prkca/prkcb knockdown. Data shown are 
means of at least three experiments +/- SEM.   
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Figure 15. PKC activity, as mediated by Gαq and PLC, is required for 
Ca2+ influx at the end of the parasite life cycle. (D) 
 
 
 
 
 
(D). Representative 45 hpi images and population-level Ca2+ measurements of P. falciparum-infected 
erythrocytes loaded with Fura-2-dextran, and immunodepleted of Gαq, PLCβ1, or PKCα/β.  Ca2+ influx was 
limited in cells depleted of these effectors, but could be rescued upon PMA treatment following Gαq or 
PLCβ1 depletion.  The mechanosensitive channel inhibitor GsTMx-4 abrogated PMA-induced Ca2+ influx, 
indicating that is influx is cation channel-dependent. Data shown are means of at least three experiments +/- 
SEM.  
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Figure 16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Mammalian PKC inhibitors show antiparasitic activity in vivo. (A). P. yoelii parasitemia 
quantified via Giemsa tail vein blood smear upon intravenous injection of 10 mg/kg Gö6976 once daily for 4 
days. (n=10; ***p<0.001). (B). T. gondii parasite burden in cells from the spleen (top) and peritoneal cavity 
(PECS; bottom) upon intraperitoneal injection of 10 mg/kg Gö6976, quantified by flow cytometry. Plots 
shown are gated on single, live cells by FSC and SSC. (n=15 for all conditions; ***p<0.0001). (C). P. berghei 
ANKA parasitemia quantified via Giemsa tail vein blood smear upon 50 mg/kg Sotrastaurin treatment via 
gastric gavage once daily for 4 days. (n=7 for all conditions; ***p<0.0001). Shown are mean parasitemias ± 
SEM. (D). Survival curves following sotrastaurin treatment using the standard Mantel-Cox log rank test 
(**p=0.0029). 
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Figure 17: Parasite TCA cycle intermediates initiate the host cytolytic 
network. (A, B). 
 
 
 
Immunofluorescence of OXGR1 and SUCNR1 within P. falciparum-infected erythrocytes (A) and T. gondii–
infected U2OS cells (B). Western blots are included as a control. (A: Red- OXGR1 (top panel)/SUCNR1 
(bottom panel), Green- His-GFP (PV); (B): Red– OXGR1 (top panel)/SUCNR1 (bottom panel), Green- P30-
GFP (PV).  
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Figure 17: Parasite TCA cycle intermediates initiate the host cytolytic 
network. (C,D) 
  
(C). Western blot confirmation of siRNA-mediated knockdown of host GPCRs and the positive control 
CAPNS1. Representative images of P30-GFP-infected U2OS knockdown cells at 44 and 60 hpi. (D). 
Quantitation of enlarged vacuoles through 60 hpi. Data shown are means of at least three experiments +/- 
SEM.  
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Figure 17: Parasite TCA cycle intermediates initiate the host cytolytic 
network. (E-G) 
 
 
 
 
 
 
 
 
(E,F). Host OXGR1 and SUCNR1 activity following T. gondii infection via measurement of Fluo-8 
fluorescence. Representative images (E) and Fluo-8 fluorescence (F) indicate host GPCR activity 
throughout the parasite life cycle. Data shown are mean fluorescence +/- SEM. (G) Unruptured vacuoles 
measured at 48 hpi following T. gondii infection of cells used in (E, F). 
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Figure 17: Parasite TCA cycle intermediates initiate the host cytolytic 
network. (H, I) 
 
 
 
(H). Time until T. gondii parasite exit upon treatment with 50 µM exogenous aKG/succinate or 50 µM lactate, 
versus 10 µM A23187 (positive control for egress induction). Data shown are mean time of at least 3 
experiments +/- SEM. (I). Representative Giemsa images following a 12-hour treatment with 50 µM 
exogenous aKG/succinate, lactate, or DMSO control. 
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Figure 18: Model of host GPCR-mediated cytolysis. 
 
Parasite ligands, perhaps upregulation of parasite TCA cycle intermediates during periods of high parasite 
replication, activate GPCRs on the PV membrane and initiate a signaling cascade through host Gαq. PKC-
mediated phosphorylation liberates adducin from the host cell cytoskeleton, activating the mechanosensitive 
plasma membrane cation channel TRPC6. CaMKII-activation following Ca2+ influx mediates phosphorylation 
of cytoskeletal substrates, which, upon rapid influx of Ca2+ from the extracellular media, are proteolyzed by 
calpain to allow for cytoskeletal dissolution and parasite release.  
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VI. Human Platelet Factor 4 and synthetic mimics: 
Harnessing host defense mechanisms for parasite death by ulcer 
The pathogenesis of malaria is modulated both positively and negatively by many 
human cell types in blood including monocytes, neutrophils and platelets (de Mast et al., 
2007; Gimenez et al., 2003; Goodier et al., 1995; Krupka et al., 2012; Mohanty et al., 
1997; Pain et al., 2001). While platelets have been long known to interact cooperatively 
with erythrocytes in thrombogenesis, both generally and in the specific case of sickle cell 
disease (Rocca and FitzGerald, 1997), only recently have platelets been shown to bind 
infected erythrocytes and kill intracellular malaria parasites (McMorran et al., 2009). 
Previous studies have suggested that thrombocytopenia is a poor prognostic marker in 
malaria (Moerman et al., 2003) and is significantly associated with cerebral malaria (Cox 
and McConkey, 2010; Wassmer et al., 2008). We were intrigued by the idea that these 
host cells found in the bloodstream are known to secrete proteins with host defense 
peptide activity (HDPs) (McMorran et al., 2009; Tang et al., 2002), and the possibility 
that these proteins could be responsible for controlling malaria parasite proliferation in 
the blood stage.   
HDPs play a central role in the innate immune system (Finlay and Hancock, 2004; 
Hancock and Lehrer, 1998; Tossi et al., 2000; Zasloff, 2002). Over 700 HDPs have been 
identified, varying in length, sequence, and tertiary structure. There are two classes of 
HDPs comprising ribosomally and nonribosomally synthesized peptides: α-helical (i.e. 
magainin and cecropin) and disulfide-rich β-sheets (i.e. bactenecin and defensin), 
although other tertiary structures also exist. Importantly, HDPs display broad-spectrum 
action against bacteria, fungi, protozoa, and viruses, which has promoted their use as 
new leads for developing antibiotics (Zasloff, 2002). HDPs share common features 
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including amphipathic topologies in which the cationic and hydrophobic side chains 
segregate onto distinctly opposing regions or faces of the overall folded conformation. 
Furthermore, numerous studies with linear and cyclic peptides have strongly supported 
the hypothesis that the physicochemical properties of HDPs, rather than any specific 
sequence or structure, are responsible for their activities. HDPs are thought to bind the 
membrane surface in a non-cooperative fashion and then aggregate once a threshold 
concentration is reached causing membrane permeabilization (Christensen et al., 1988; 
Ludtke et al., 1995; Matsuzaki et al., 1995, 1996; Pouny et al., 1992). It is generally 
believed that amphipathic topology is essential for insertion into and disruption of 
membranes leading to pathogen death (Zasloff, 2002). HDPs have remained an effective 
weapon against pathogen infection over time indicating that their mechanism of action 
thwarts pathogen responses, which normally lead to resistance against toxic 
substances. This premise is supported by data showing that no appreciable resistance 
to the action of the HDPs occurs after multiple serial passages of bacteria in the 
presence of sub-lethal concentrations of the peptides (Ge et al., 1999; Mosca et al., 
2000; Tew et al., 2002). From this background, we hypothesized that naturally occurring 
bloodstream HDPs especially from platelets could be responsible for killing of P. 
falciparum early in erythrocytic infection, aside from cerebral malaria symptomology. 
Identification of human platelet factor 4 (hPF4) as an antiparasitic HDP that kills P. 
falciparum via lysis of the parasite DV 
A screen of HDPs normally found in the bloodstream, secreted by a variety of cells 
including platelets, neutrophils, or lymphocytes, was performed to assess their anti-
parasitic activity (Figure 19A). This screen revealed that several proteins killed P. 
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falciparum in vitro without affecting the host erythrocyte. Most notably, hPF4 showed 
high potency against P. falciparum with an IC50 of 4.2 µM and no significant hemolysis. 
Considering local concentrations of hPF4 have been reported to reach at least 280 µM 
surrounding activated platelets (Kowalska et al., 2010), the antiparasitic IC50 of hPF4 has 
in vivo relevance. We thus focused our efforts on studying PF4 to determine the 
biological relevance of its potential antimalarial properties. Platelets harvested from wild-
type (WT), mouse PF4 (mPF4) knock-out (mPF4 KO), or overexpressing hPF4 (hPF4+) 
mice were tested against P. falciparum in culture with recombinant mPF4 and hPF4 as 
controls (Figure 19B). Pre-activated WT and hPF4+ mouse platelets were able to kill P. 
falciparum in culture, while littermate PF4 KO platelets showed no killing capacity. Thus 
it appears that PF4 is the major antimalarial component of activated platelets. 
As membrane perturbation is an established mechanism of action for HDPs 
(Burkhard, 2009; Lehrer et al., 1989; Matsuzaki et al., 1997; Westerhoff et al., 1989; 
Zasloff, 2002), we examined the integrity of potential target parasite membranes upon 
hPF4 treatment. Since hPF4 had little hemolytic capability we reasoned the erythrocyte 
integrity was not significantly compromised. Parasite plasma membrane (PPM) potential 
assays showed no discernible loss of potential following 4 hours of hPF4 exposure 
(Figure 19C). Next the integrity of established intracellular organelle targets, including 
the mitochondria and lysosome-like DV was assessed post hPF4 treatment. Analysis of 
membrane potential revealed no perturbation of the mitochondria, however a significant 
loss of proton potential was observed in the DV within minutes of treatment (Figure 
19C). To further investigate this novel perturbation to the DV, transgenic parasites 
expressing green fluorescent protein (GFP)-tagged plasmepsin II in the DV (Klemba et 
al., 2004) were treated with hPF4 and followed by fluorescence microscopy over a 10-
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minute time course. Parasites were assayed for both hPF4 localization using 
immunofluorescence analysis (IFA) and direct GFP signal (integrity of the DV; Figure 
19D). Within 1 minute of hPF4 incubation, hPF4 staining could be detected in the 
cytoplasm of only infected erythrocytes. hPF4 continued to accumulate over the next 
several minutes, wherein it entered the parasite cytoplasm and colocalized with the 
parasite DV. Next, severe perturbation of the DV allowed GFP to diffuse throughout the 
parasite cytoplasm (Figure 19D, Figure 20A,B). Western blot analysis of hPF4 
confirmed the IFA results showing entry into erythrocytes by 1 minute followed by 
accumulation into the parasite within 5 minutes (Figure 19E). To assess the loss of DV 
integrity on the population level, we utilized ImageStream flow cytometry to first capture 
images of individual parasite-infected cells, then quantitatively differentiate based on DV 
fluorescent surface area (SA) intact DVs (<0.2 µm2) from lysed DVs (>2 µm2; Figure 
19F, Figure 20C). hPF4 treatment caused dose-dependent DV lysis, with nearly 
complete DV lysis on a population level upon exposure to 10 µM hPF4. The loss of DV 
integrity was confirmed at high resolution using transmission electron microscopy 
imaging to compare untreated and hPF4-treated parasites revealing the complete loss of 
DV integrity in the hPF4-treated parasites versus mock-treated parasites with a clearly 
delineated DV membrane (white arrowheads; Figure 19G). In addition to the loss of DV 
organellar structure, hemozoin crystals were seen dispersed throughout the parasite (red 
arrowheads). Thus, DV lysis appears to be the primary and novel mechanism of hPF4 
action against parasites.  
In contrast, the only other human HDP tested against P. falciparum is NK-2, secreted 
by lymphocytes, which was shown to kill P. falciparum by direct perturbation of the 
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infected erythrocyte plasma membrane (Gelhaus et al., 2008). Dermaseptins, HDPs 
from the skin of hylid frogs, were demonstrated to kill parasites by perturbation of the 
infected erythrocyte plasma membrane or the parasite plasma membrane (Dagan et al., 
2002; Ghosh et al., 1997). However, the high hemolytic potential of dermaseptins and 
the fact they are not of human origin makes the therapeutic relevance of these findings 
unclear.  Though the mode of entry into cells is unclear, given that there are 4 
membrane systems that must be bypassed prior to selective interaction with the DV 
membrane, we provide evidence that hPF4 enters only infected erythrocytes and that 
this entry process can be blocked by protamine sulfate (Figure 20D). This indicates the 
importance of initial electrostatic interactions with the infected host cell membrane or 
membrane proteins. Stage specificity studies indicate that hPF4 is most potent during 
parasite stages that heavily rely on digestive vacuole function (Figure 20E), perhaps 
indicating that hPF4 is incorporated into the parasite body during hemoglobin uptake. 
In order to obtain proof of concept that HDPs kill parasites in blood stage malaria 
infection, we tested PF4 in a non-experimental cerebral malaria (non-ECM) murine 
malaria model using the 4-day Peters suppression test (Knight and Peters, 1980). Mice 
infected with P. yoelii 17XNL were administered 10 mg/kg mPF4 intravenously on days 
1-3, and parasitemias were assessed on day 4. mPF4 treatment significantly reduced 
parasitemia by 4-fold (Figure 20F). 
Synthetic small molecule HDP mimics are potent against P. falciparum and have a 
mechanism similar to hPF4 
Given their broad activity, HDPs appear to be ideal therapeutic agents, though 
significant pharmaceutical issues have severely hampered clinical progress, including 
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poor tissue distribution, systemic toxicity, and difficulty and expense of manufacturing 
(Easton et al., 2009). In addition, PF4 has been reported to worsen experimental 
cerebral pathology in mice, presumably mediated through the chemokine domain 
(Srivastava et al., 2008). Thus, we reasoned that synthetic small molecules capable of 
adopting amphipathic secondary structures analogous to an HDP could potentially 
reproduce the potent, selective antiparasitic activity of PF4, while improving tissue 
distribution and decreasing complications arising from chemokine signaling. In addition, 
these small molecule HDP mimics (smHDPs) are significantly less expensive to produce 
(an example scaffold is shown in Figure 21A). In order to exploit the DV lysis 
mechanism of PF4 in a drug discovery effort, a library of ~1000 non-peptidic smHDPs 
(Mensa et al., 2011; Scott et al., 2008) was tested against P. falciparum. 132 
compounds were determined to be initial “hits” (14.3% hit rate), using a cutoff of 80% 
parasite death at 1 µM (Z’ = 0.720; Figure 21B). 74 compounds were selected for 
follow-up IC50 determination (Table 6). Based on these hits, additional compounds were 
synthesized and 7 structurally diverse compounds were chosen as “leads” based on 
high potency against P. falciparum, low hemolytic potential, and low mammalian cell 
cytotoxicity. These lead compounds also showed similar potency across a panel of 
chloroquine-sensitive (3D7, HB3) and chloroquine-resistant (Dd2, 7G8, K1) parasite 
lines, both lab-adapted (Table 7) and short-term adapted field isolates (Table 8). 
Several of the lead compounds displayed little activity against Gram-positive and Gram-
negative bacteria, as well as mammalian cells, indicating that a high level of specificity 
can be built into these non-peptidic scaffolds that can distinguish between prokaryotic 
and eukaryotic pathogens. Although all lead compounds showed a similar mechanism of 
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action as PF4, based on acute animal tolerability studies, PMX1207 and PMX207 were 
selected for more rigorous mechanistic analysis. 
Treatment of P. falciparum parasites with either PMX1207 or PMX207 disrupted DV 
membrane integrity within 15 minutes of treatment but did not disturb the PPM or 
mitochondrial potential, even after 4-hour treatment (Figure 22A). In addition, treatment 
of the transgenic PMII-GFP parasites with PMX1207 and PMX207 resulted in rapid 
diffusion of GFP through the parasite cytoplasm indicating a catastrophic loss of DV 
membrane integrity in a manner similar to that observed for hPF4 (Figure 22B). 
ImageStream flow cytometry analysis indicated a dose-dependent effect on DV lysis, 
with nearly complete DV lysis within the treated population upon treatment with 1 µM of 
PMX207 or PMX1207 (Figure 22C). Similarly, 7 additional smHDPs showed rapid lysis 
of the DV upon treatment (Figure 23A). 
We further investigated the intracellular localization and distribution of the smHDPs 
using PMX496, a potent smHDP with intrinsic fluorescence. PMX496 appeared to 
accumulate in the parasite body within 30 seconds, then concentrated in the DV at 1 
minute, prior to dissipation throughout the parasite body, indicating a loss of DV 
membrane integrity (Figure 23B). Since cationic amphipathicity is predicted to be 
necessary for smHDP antiparasitic action, an uncharged isosteric analog of PMX496 
was synthesized (PMX1269, IC50 > 2.5 µM). As expected, treatment with the uncharged 
analog did not result in DV lysis. High-resolution transmission electron microscopy and 
3D tomograms revealed a complete loss of integrity of the DV after treatment with either 
PMX1207 or PMX207 (Figure 22E). In addition to free hemozoin crystals (red 
arrowheads), images showed an accumulation of undigested hemoglobin-containing 
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vesicles (yellow arrowheads; Figure 22E, Figure 23E). Mock-treated parasites showed 
clear delineating DV membranes (white arrowheads). DV lysis and killing was also 
evident in Texas Red Dextran-loaded erythrocytes infected with either trophozoite-stage 
parasites (Figure 23C) or gametocytes (Figure 23D). Although we cannot discern 
whether gametocytes are dying from this data, loss of DV integrity would likely result in 
death and this possibility indicates that smHDPs may have transmission-blocking 
potential. 
smHDP activity reduces parasitemia in a murine malaria model 
In order to further explore the antimalarial properties of lead smHDPs, PMX207 and 
PMX1207 were assessed for their ability to limit parasite growth in vivo. PMX207 and 
PMX1207 antiparasitic activity was assessed in a non-ECM murine malaria model using 
the 4-day Peters suppression test (Figure 22E). Mice were inoculated intravenously on 
day 1 with 2 x 105 P. yoelii XNL-infected erythrocytes and then treated with 10 or 20 
mg/kg of PMX207, 5 mg/kg PMX1207, or vehicle alone for 3 days and parasitemias were 
monitored on day 4. PMX207 showed a dose-dependent decrease in parasite growth, 
with 20 mg/kg, almost completely eliminating parasitemia (Figure 22F,G). PMX1207 
showed a significant decrease in parasite growth, suppressing parasitemia 5-fold over 
vehicle-treated controls. These data provide in vivo validation that smHDP compounds 
show promise as a new class of antimalarials. 
Discussion 
HDPs are extremely diverse not only in structure, but in cellular targets and mode of 
action. HDPs have been shown to kill pathogens via a variety of mechanisms: simply via 
perturbation of the pathogen plasma membrane (Chao and Raines, 2011; Duchardt et 
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al., 2007; Haines et al., 2009; Mochon and Liu, 2008) or intracellular membranes such 
as mitochondria (Slaninova et al., 2012), or through immune modulation (D'Este et al., 
2012; Repeke et al., 2011; Williams et al., 2012; Wuerth and Hancock, 2011). However, 
there is a distinct lack of examples that involve perturbation of pathogen 
endosomes/lysosomes, aside from the killing of the distantly related protozoan parasite, 
T. brucei brucei, in an HDP-like manner by a human protein, trypanosome lytic factor 
(TLF). TLF has been shown to cause lysis of parasite endosomes/lysosomes conferring 
a species barrier and protection for humans against infection (Harrington et al., 2009; 
Rifkin, 1978; Samanovic et al., 2009; Smith et al., 1995).  
Finally, we present a model for the mechanism of action for these HDPs or small 
molecule mimics, which begins upon uptake of these molecules into the host erythrocyte 
cytoplasm, possibly through a parasite-mediated mechanism (Figure 24A). Once inside 
the host cell cytoplasm, these HDP molecules are targeted to the DV along with 
hemoglobin through the cytostome (Goldberg, 1993) and carried to the DV via 
hemoglobin-containing vesicles. Once inside the DV, the HDP or smHDP is released 
along with the hemoglobin cargo, accumulates and binds to the membrane directly. At a 
critical concentration, these HDPs disrupt the integrity of the DV membrane and release 
the contents, which include numerous proteases and hydrolases, into the cytoplasm of 
the parasite (Figure 24B). Destruction of proteins and organelles leads to rapid parasite 
death (Figure 24C).  
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Table 6 
Compound 3D7 IC50 (nM) Dd2 IC50 (nM) Compound 3D7 IC50 (nM) Dd2 IC50 (nM) 
Chloroquine 8.7 24.6 614 864 966 
Artesunate 19.4 12.1 616 149 97 
004 563 740 617 110 172 
015 438 601 633 272 457 
018 668 611 647 160 300 
033 306 419 651 148 267 
048 295 484 661 175 200 
053 740 1154 730 1150 975 
056 653 993 731 1164 964 
058 1233 1219 734 610 980 
062 413 426 781 147 207 
073 204 274 800 610 431 
092 1024 713 819 724 951 
112 688 740 832 358 368 
143 870 688 835 220 300 
146 322 244 847 870 1076 
152 221 170 848 625 709 
158 683 827 868 881 886 
160 151 168 893 200 301 
192 1198 1010 1007 1283 2747 
201 125 85 1011 880 795 
207 153 134 1012 656 555 
217 569 591 1032 1197 798 
224 893 524 1045 706 398 
235 146 108 1064 1098 1132 
256 1064 344 1065 680 664 
270 732 803 1068 644 682 
459 1365 1632 1070 650 724 
462 1283 2120 1076 N/A N/A 
474 991 1226 1086 812 1054 
484 655 1095 1088 734 602 
485 841 1006 1095 1141 786 
493 904 1183 1096 58 90 
496 160 170 1099 1163 667 
501 593 393 1101 672 656 
504 160 118 1107 1102 997 
610 N/A N/A 1115 696 829 
611 60 49 1120 308 331 
 
1154 530 N/T 1284 160 135 
1158 563 N/T 1287 2819 N/T 
1159 493 N/T 1301 226 N/T 
1164 N/A N/T 1302 160 132  
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1165 161 N/T 1305 N/A N/T 
1170 81 N/T 1306 1299 N/T 
1179 1125 N/T 1307 1256 N/T 
1185 15.5 N/T 1308 629 N/T 
1199 2932 N/T 1310 2203 N/T 
1200 2681 N/T 1324 602 N/T 
1201 3376 N/T 1325 112 N/T 
1206 3284 N/T 1338 N/A N/T 
1207 110 75 1364 N/A N/T 
1209 1503 N/T 1374 641 N/T 
1210 658 N/T 1375 88.3 N/T 
1211 976 N/T 1382 126 N/T 
1213 N/A N/T 1387 N/A N/T 
1219 3050 N/T 1398 131 N/T 
1220 N/A N/T 1399 N/A N/T 
1221 N/A N/T 1400 473 N/T 
1222 3603 N/T 1403 116 N/T 
1223 3079 N/T 1407 795 N/T 
1224 297 N/T 1408 77.1 N/T 
1226 2523 N/T 1410 N/A N/T 
1229 202 N/T 1411 N/A N/T 
1237 255 N/T 1412 N/A N/T 
1249 1716 N/T 1413 N/A N/T 
1258 247 N/T 1414 N/A N/T 
1260 N/A N/T 1415 N/A N/T 
1267 N/A N/T 1416 N/A N/T 
1268 3480 N/T 1417 N/A N/T 
1269 3029 N/T 1418 187 N/T 
1271 2318 N/T 1422 738 N/T 
1283 2445 N/T    
N/A = Not Active 
N/T = Not Tested 
 
Table 6. IC50 values determined in 3D7 (CQ-sensitive) and Dd2 (CQ-resistant) P. falciparum for 74 hits from 
smHDP screen and derivative compounds not included in original screen. Parasites were treated in 
triplicate, n = 2.  
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Table 7 
 
Table 7. smHDPs show potency across several chloroquine-sensitive and chloroquine-resistant P. 
falciparum strains, with little cytotoxicity against mammalian cells. Lead smHDPs were screened 
against a panel of chloroquine-sensitive and chloroquine-resistant P. falciparum lines. Chloroquine was used 
as a positive control for parasite death. IC50s are as mean ± SEM, n>3 for each compound. Cytotoxicity 
(EC50) determined against mouse 3T3 fibroblasts and human transformed liver HepG2 cells using an MTS 
viability assay. 
 
Table 8 
 
 
 
 
 
 
 
 
 
 
 
Table 8. Lead smHDPs show potency across several chloroquine-sensitive and chloroquine-
resistant P. falciparum field isolates. Lead smHDPs were screened against a panel of chloroquine-
sensitive and chloroquine-resistant P. falciparum lines. Chloroquine was used as a positive control for 
parasite death. IC50s are as mean ± SEM, n>3 for each compound. Cytotoxicity (EC50) determined against 
mouse 3T3 fibroblasts and human transformed liver HepG2 cells using an MTS viability assay. 
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 Figure 19. hPF4 acts as a HDP against P. falciparum via lysis of the 
parasite DV. (A,B) 
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Figure 19. hPF4 acts as a HDP against P. falciparum via lysis of the 
parasite DV. (C-E) 
 
 
 (C) Parasite-infected erythrocytes pre-incubated with rhodamine 123 (1 µM for parasite plasma membrane 
potential; 0.2 µM for mitochondrial potential) or 10 nM LysoTracker Red and then treated over a 4-hr time 
course with 10 µM PF4 or a 10 µM mixture of ionophores Monensin and Nigericin (Mon/Nig). Length bar is 
10 µm in each figure. (D) hPF4 accumulates in the infected erythrocyte cytoplasm prior to lysis of the DV by 
immunofluorescence. Erythrocytes infected with parasites expressing plasmepsin-II-GFP (PM-II-GFP) were 
treated with 1 µM hPF4 over a 10 min time course. Within 1 minute of PF4 incubation, PF4 staining is seen 
in the cytoplasm of infected erythrocytes until entering and inducing lysis of the parasite DV, as shown by 
GFP signal diffusion through the entire parasite cytoplasm. (Green: PM-II-GFP [DV]; red: hPF4 IFA; blue: 
parasite nuclei.) (E) Western blot analysis of erythrocyte fractions or parasite lysates shows early 
accumulation of hPF4 in infected erythrocytes, followed by persistence in the parasite.  
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Figure 19. hPF4 acts as a HDP against P. falciparum via lysis of the 
parasite DV. (F, G) 
  
 
 
(F) ImageStream flow cytometry shows a dose-dependent increase in PM-II-GFP parasites with a 
fluorescence surface area of >2 µm2, an indication of DV lysis, upon treatment with hPF4. Intact DVs have 
fluorescent surface areas <0.2 µm2. Data shown are means ± SEM. (*p<0.05, **p<0.01) (G) TEM images 
reveal dissolution of the DV membrane upon treatment with 10 µM PF4, as well as dispersal of hemozoin 
fragments throughout the cytoplasm (red arrowheads). Mock-treated controls showed complete integrity of 
the DV membrane (white arrowheads), encapsulating all hemozoin crystals. (N: parasite nucleus).  
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Figure 20. hPF4 causes dose-dependent DV lysis and reduces 
parasitemia in a mouse malaria model. (A-C)	  
	  
	  
	  
	  (A) Trophozoite-infected Texas Red Dextran-loaded erythrocytes show dispersal of fluorescence into the 
parasite cytoplasm (indicating DV lysis) following 5 min of treatment with hPF4.  (B) Gametocyte-infected 
Texas Red Dextran-loaded cells show dispersal of fluorescence into the parasite cytoplasm (indicating DV 
lysis) upon 5 min of treatment with hPF4. (C) Representative flow plots from mock-treated parasites 
expressing PM-II-GFP or parasites treated with 1 µM hPF4, 3 µM hPF4, or 10 µM hPF4. Synchronous PM-II 
parasites were used to examine DV integrity upon treatment. DV lysis is defined as area of GFP signal 
greater than 2 µm2 (red line is minimum area), as GFP signal would disperse into the entire parasite 
cytoplasm. Intact DVs show compact area (less than 0.2 µm2; blue line is maximum area).  
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Figure 20. hPF4 causes dose-dependent DV lysis and reduces 
parasitemia in a mouse malaria model. (D, E)	  
 
(D) PM-II-GFP parasite-infected erythrocytes were pretreated with 5 mM protamine sulfate or mock (DMSO) 
or 30 minutes, then treated with 10 µM hPF4 for 10 minutes prior to fixation and permeabilization.  hPF4 
immunofluorescence (red) shows no appreciable signal in the protamine sulfate pretreated erythrocytes, 
while mock-pretreated erythrocytes show hPF4 accumulation within the erythrocyte. (red: hPF4 IFA; green: 
PM-II-GFP; blue: parasite nuclei). (E) Stage-specific killing of PF4 shows increased efficacy during the 
stages that rely heavily on DV function (late ring, trophozite, schizont, gametocyte). Shown are means ± 
SEM; n=3.  
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Figure 20. hPF4 causes dose-dependent DV lysis and reduces 
parasitemia in a mouse malaria model. (F) 
 
	  
 (F) Mice infected with P. yoelii 17XNL show decreased parasitemia on day 4 when treated with 10 mg/kg 
mPF4 (n=3) compared to controls (n=5, p < 0.001). Shown are mean parasitemias ± SEM.	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
	  
115	  
Figure 21. Screen of smHDPs reveals potent inhibitors of  
P. falciparum growth.
 
(A) Conceptual design of smHDPs from HDPs. Top: Amphipathic structure of magainin 2; cationic groups in 
blue, nonpolar groups in green, peptide backbone in yellow. Bottom: de novo designed smHDPs capture the 
facially amphipathic architecture and critical physicochemical properties needed to establish robust 
antimicrobial activity. (B) Screen of 920 smHDPs at 500 nM against P. falciparum. Parasite death was 
normalized to a chloroquine control (14.3% hit rate, Z’ = 0.720).  
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 Figure 22. smHDP leads kill P. falciparum via parasite DV lysis and 
decrease parasitemia in a murine malaria model. 
 (A) Parasite plasma membrane and mitochondrial potential were examined during treatment with PMX207 
or PMX1207, with no discernible loss of fluorescence, unlike the positive controls. Compromise of DV 
integrity was monitored with LysoTracker Red, wherein loss of DV fluorescence was seen within 15 min of 
smHDP treatment, though no loss of parasite plasma membrane potential occurs. (B) Loss of DV integrity 
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upon smHDP treatment of PM-II-GFP P. falciparum parasites (Green: PMII-GFP [DV]; blue: parasite nuclei.) 
(C) ImageStream flow cytometry shows a dose-dependent increase in PM-II-GFP parasites showing a 
fluorescence surface area of >2 µm2, an indication of DV lysis, upon treatment with PMX207 or PMX1207. 
Intact DVs have fluorescent surface areas <0.2 µm2. Data shown are means ± SEM. (*p<0.05, **p<0.01) (D) 
TEM images reveal complete dissolution of the DV membrane upon PMX207 or PMX1207 treatment, with 
dispersal of hemozoin crystals (red arrowheads) throughout the cytoplasm and an accumulation of 
undigested hemoglobin-containing vesicles (yellow arrowheads). Mock-treated parasites retained a clear 
delineating DV membrane (white arrowheads), encapsulating all hemozoin crystals. (N: parasite nucleus). 
(E) Parasitemias of Swiss Webster mice infected with P. yoelii 17XNL parasitized erythrocytes via i.v. 
injection and treated with vehicle (n=5); 5 mg/kg PMX1207 (n=7); or 20 mg/kg of PMX207 (n=5). 
Parasitemia was assessed on days 4 and 6. Shown are the means ± SEM. (*p<0.05; ***p<0.001) (F) 
Parasitemias of C57Bl/6 mice infected with P. berghei ANKA parasitized erythrocytes via i.v. injection and 
treated with vehicle (n=10); 5 mg/kg PMX1207 (n=5); or 20 mg/kg of PMX207 (n=5). Parasitemia was 
assessed on days 5 and 7. Shown are the means ± SEM. (*p<0.05; ***p<0.001). (G) Survival curves for P. 
berghei ANKA infected mice. p = 0.14 in the log-rank Mantel-Cox test. 
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Figure 23. smHDPs require a facial charge density to lyse the parasite 
DV. 
  
 (A) Visualization of DV lysis by smHDPs by fluorescence microscopy. PM-II-GFP P. falciparum parasites 
were treated with compounds PMX504, PMX611, PMX647, PMX835, PMX496, or PMX1269 (250 nM) over 
a 5-min time course and imaged via fluorescent microscopy. In untreated parasites, the GFP signal is an 
isolated structure, indicating an intact DV. The GFP signal after smHDP treatment spans the entire parasite 
body, indicating loss of digestive vacuole integrity. The uncharged analogue of PMX496, PMX1269, did not 
cause DV lysis. (Green: PM-II-GFP; blue: parasite nuclei.) (B) Fluorescent microscopy of the intrinsically 
fluorescent PMX496 shows accumulation within the parasite cytoplasm and DV prior to DV lysis. (C,D) 
Visualization of DV lysis by PMX1207 with Texas Red Dextran-loaded erythrocytes. Trophozoite- (C) or 
Gametocyte-infected (D) Texas Red Dextran-loaded cells show dispersal of fluorescence into the parasite 
cytoplasm following treatment with PMX1207, indicating loss of DV integrity. (E) Number of hemoglobin-
containing vesicles in electron micrographs of parasites treated with 10 µM hPF4, 500 nM PMX207, or 
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500nM PMX1207 was counted and compared to mock (DMSO)-treated controls.  Data shown is mean ± 
standard deviation of 50 parasites (*p<0.05). 
 
 
 
Figure 24 
 
 
Figure 24. Model of PF4 and smHDP uptake. Proposed mechanism of parasite uptake of PF4 and 
smHDPs. (A) Molecules reach the host erythrocyte cytoplasm, possibly via either an active mechanism 
(Route 1) or a passive mechanism (Route 2) initiated by the parasite during hemoglobin uptake through the 
cytostome (c) and packaging into double membranous hemoglobin-containing vesicles (HV). HVs are then 
targeted to the DV where the contents are released into the DV lumen. (B) As the parasite continues to take 
up host cell cytoplasm, the HDPs or derivatives eventually reach a critical concentration within the DV, bind 
to the inner leaflet of the DV membrane, and disrupt its integrity, allowing the contents to enter the 
cytoplasm of the parasite. (C) Rapid destruction of proteins and organelles cause parasite death. 
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VII. CONCLUSIONS AND FUTURE DIRECTIONS 
 
Through focused characterization of host-parasite interactions that could be 
exploited to strengthen development of novel antiparasitics, we hoped to achieve 
a paradigm shift to establish that multiple host proteins/pathways are essential 
for apicomplexan parasite growth, and may be exploited to generate novel drug 
classes with limited propensity for resistance. In addition, we wished to establish 
commonalities and differences between the distantly related apicomplexan 
parasites, Toxoplasma and Plasmodium, with the hope that these common host 
proteins co-opted by these parasites might be used by other protozoa such as 
the poorly studied, biodefense class B parasite Cryptosporidium parvum. 
Ultimately, the concept of inhibiting host factors necessary for parasite growth or 
optimizing innate antiparasitic molecules may prove an effective therapeutic 
strategy for multiple intracellular parasites, as inhibition of these targets will 
necessarily limit drug resistance. We hope that one or more host proteins will 
emerge as novel therapeutic targets or provide the basis for novel therapeutics 
that will drive antiparasitic drug development.  
 
Targeting host molecules required for parasite life cycle progression: 
Can we beat them at their own game? 
An assessment of the parasite life cycle allowed us to identify necessary interactions 
with the host, without which the parasite would be unable to proliferate: it is clear that the 
parasite interacts with the host upon invasion, to obtain nutrients, and ultimately to lyse 
and leave the host cell. As the process of parasite egress was not well characterized 
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relative to the process of invasion, we believed that this process likely provided a wealth 
of untapped resources for antiparasitic drug development: they only had to be 
characterized. This act of egress is thought to take place in seconds at the end of the 
48-hour erythrocytic cycle through the complete destruction of the host erythrocyte. 
From our prior work demonstrating that parasites require human calpain [15], we 
hypothesized that host calpain is used to destabilize the erythrocyte membrane. In this 
work, we endeavored to provide a more global understanding of changes that occur to 
the host erythrocyte membrane proteome during parasite egress and furthered identified 
a complex GPCR-driven host pathway necessary for cytoskeletal compromise prior to 
parasite release. 
Together, these data suggest that parasite egress does not occur as a single 
explosive event just at the end of the 48-hour life cycle. More accurately, the distinct 
events of cytoskeletal dismantling, which we now demonstrate, suggest a systematic 
preparation for egress that takes place over at least 15-20 hours in which the parasite 
gradually disrupts the cytoskeleton to ultimately allow for facile escape. Though this work 
represented a concentrated effort, we submit that these results do not provide an 
exhaustive identification of host protein involvement in parasite growth. A combination of 
genetic, proteomic, biochemical, and in vivo approaches will likely be required to 
systemically identify and characterize host proteins required for parasite life cycle 
progression through invasion, replication, and egress: 
1. Genome-wide screens to define host genes involved in T. gondii growth.  
Aside from our data implicating multiple host proteins during parasite egress 
(Chandramohanadas et al., 2009) and host actin polymerization (Gonzalez et al., 2009) 
during parasite invasion no host proteins have been identified to be required for 
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intracellular parasite replication or growth. To determine additional host factors involved 
in this process using an unbiased approach to identify host genes important for parasite 
growth, systematic knockdown using should be used. 
 
2. Targeted siRNA screen for host proteins involved in parasite invasion. 
Though we have made significant strides in the study of host proteins that function in 
parasite exit, little is known about host proteins involved in parasite invasion.  In fact, it 
has historically been assumed that the host cell remains quiescent during this process, 
as much attention has been paid to parasite-derived proteins that function in invasion.  
 
3. Quantitative proteomics studies to discover host proteins that change in 
response to T. gondii infection.  
As a complementary approach, quantitative proteomics studies will allow the 
determination of host proteins that change in abundance during parasite infection. This 
approach will involve the use of SILAC-labeling and mass spectrometry-based 
sequencing (Ong et al., 2002) in host cells to discover new host-parasite interactions. 
Proteins that significantly change in abundance (>3 fold change) up or down may 
represent host proteins modified directly or indirectly by the parasite to allow for 
progression of its life cycle.  
4. Assessing the role of host proteins during parasite infection in vivo. 
While we have demonstrated that calpains have a key role in parasite egress in cell 
culture models (Chandramohanadas et al., 2009), it is important to explore the in vivo 
physiological importance of the GPCR and calpain-mediated egress pathway using 
mouse models of parasite infection. Validation of this pathway in animal models would 
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provide an important proof of principle to justify future therapeutic development. 
Importantly, although calpain-2 is essential for embryonic development, pharmacological 
inhibition of calpain-1/2 in adult mice was well tolerated (Mamoune et al., 2003) and 
genetic ablation of both calpain-1 and calpain-2 using tissue-specific or regulated 
conditional CAPN4 knockout approaches have resulted in viable mice with subtle 
physiological defects (Kashiwagi et al.; Shimada et al., 2008; Tan et al., 2006; 
Wernimont et al.). Furthermore, knockout approaches involving multiple PKC family 
members have been unsuccessful. Collectively, these observations bode well for the 
potential clinical use of selective and effective inhibitors, as well as conditional knockout 
systems.  
Mice that are either heterozygous or homozygous knockouts of any of host gene 
“hits” from the RNAi screen should be challenged with both T. gondii, P. yoelli, and P. 
berghei ANKA. The mouse malaria model P. yoelii is useful as this species models 
severe non-cerebral malaria, the time course of infection is short, and the outcome 
(survival vs. lethality) is definitive. The P. berghei ANKA mouse model, in contrast, 
models cerebral malaria, allowing for differential investigation of host protein involvement 
in different models of disease. The effect of genetic depletion of screen hits on parasite 
infection should be compared with that achieved using standard anti-malarial drugs 
including artemisinin and atovaquone, as well as that seen using specific inhibitors. 
 
PF4 and Small molecule mimics of host defense peptides: 
Can we optimize an evolutionarily-tuned host defense? 
In addition to identifying host proteins exploited by the parasite for life cycle 
progression, we were interested in characterizing host proteins that naturally act as 
antiparasitics via exploitation of a fundamental host-parasite interaction. 
	  
	  
124	  
In this work we identified the human HDP protein, PF4, as an antiparasitic molecule 
that kills Plasmodium parasites by lysing the parasite DV, a vital parasite organ 
responsible for digestion of host hemoglobin. Targeting the lysosome-like vesicles of 
protozoan parasites may be an evolutionarily selected mechanism for mammalian hosts 
to kill Plasmodium and other parasites (i.e. T. brucei). How proteins such as PF4 enter 
host cells remains an open question, though uptake of hPF4 into the host erythrocyte 
seems to diminish following parasite DV lysis and parasite death, suggesting that 
perhaps an active, parasite-mediated mechanism allows entry of these HDP molecules 
into the erythrocyte cytoplasm. Since only infected cells are targeted, and parasite 
viability is important for uptake, this suggests that perhaps a parasite-derived or 
activated endocytosis-like mechanism could allow for large molecules such as PF4 to 
enter, while perhaps channels or pores could be responsible for small molecule uptake 
(Baumeister et al., 2006; Elford et al., 1990; Kirk and Horner, 1995).  
We believe that human PF4 likely has a natural role in controlling blood stage 
parasite growth, and that its low hemolytic potential and selective targeting of the 
parasite DV endow it with properties that are well tolerated in the bloodstream. However, 
it is unlikely that PF4 would make a useful therapeutic for malaria treatment due to the 
cost of goods, and potential of inflammatory damage through its chemokine domain 
during cerebral malarial. Thus screening for smHDPs with a similar mechanism of action 
may avoid the issues of PF4 while preserving its unique mechanism of action and safety; 
as such, smHDPs may represent a new class of small molecules with effective 
therapeutic potential for combating this human disease where efforts are currently 
challenged with rampant drug resistance. In order to optimize these molecules as potent 
antiparasitics, it will be necessary to understand the unique properties of parasite 
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membranes that engender this specificity and the PF4 domains responsible for this 
antiparasitic activity, as well as resistance studies, development of analogues, and in 
vivo studies: 
5. Testing PF4 against model liposomes based on the composition of 
parasite digestive vacuolar membranes. To determine why PF4 selectively 
disrupts the digestive vacuole membrane causing leakage of digestive vacuole contents 
via direct membrane disruption, model liposomes with similar lipid content to the parasite 
digestive vacuole membrane should be prepared prior to assessment of membrane 
compromise upon PF4 treatment. The composition of parasite digestive vacuole 
membranes can be determined via the isolation of this organelle from whole parasites 
(Goldberg et al., 1990) and analysis of lipid content within these purified preparations via 
Liquid Chromatography/Mass Spectrometry (LCMS) (Ham et al., 2004).  
6. Understanding the basis of selective entry of PF4 into infected 
erythrocytes. Our preliminary data shows that only infected erythrocytes take up PF4 
and that pretreatment with protamine sulfate blocks both entry and activity of PF4 
against P. falciparum. This allows us to hypothesize that initial interaction between PF4 
and the parasitized erythrocyte is electrostatic and involves binding to negatively 
charged molecules on the surface. Considering that the erythrocyte surface proteins 
such as the glycophorins are highly decorated with sialic acid, we can directly test 
whether sialic acid is involved in the initial binding events by specifically stripping it off 
using neuraminidase.   
7. Generating PF4-resistant parasites. Since HDP-mediated cell death via 
membrane perturbation is not reliant upon a specific receptor or intracellular protein 
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target, cellular resistance to such compounds should be difficult to generate. In order to 
test this hypothesis, P. falciparum lines that are resistant to PF4 should be attempted to 
be generated via serial passaging in dilutions of our experimentally determined PF4 IC50 
(0.25 x IC50, 0.5 x IC50, and the full IC50 concentration).  As a control, parallel cultures 
should also be exposed to 0.5x IC50 concentration of pyrimethamine, a well-established 
antiparasitic for which resistance has been reported. This should be carried out over a 
time period of at least 6 months.  If resistant lines are successfully generated, tiling 
microarrays should be used to determine any genes that contribute to resistance.  
Resistance would indicate that PF4 might not be acting solely via membrane disruption. 
Conversely, if parasites fail to generate resistance to these compounds, this class of 
compounds may have potential as antimalarials that may elicit minimal parasite 
resistance. 
8. Assessing the in vivo role of PF4 during parasite infections in genetically 
modified mice.  
PF4 (CXCL4) belongs to the CXC family of chemokines that has a putative HDP domain 
at the C-terminus. PF4 can be released upon activation from alpha-granules of blood 
platelets in very high physiologic concentrations, locally up to 100 mM (Lambert et al., 
2007b). Until recently, CXCL4 gene expression was thought to be restricted to 
megakaryocytes (Brandt et al., 2000), but other cell types may produce these 
chemokines as well (Schaffner et al., 2005). The Poncz laboratory was the first to 
develop PF4 knockout mice (Eslin et al., 2004b) and also transgenic mice that 
overexpress human PF4 (hPF4+; (Zhang et al., 2001)). These mice are valuable tools 
for the study of PF4 in vivo in several disease models including thrombus formation, 
atherosclerosis, megakaryopoiesis, liver fibrosis, angiogenesis and tumor formation. In 
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this proposal we aim to use these mice to understand the in vivo relevance of platelet 
secreted PF4 in both the severe anemic model of malaria using P. yoelii (which causes 
disease in the peripheral vasculature and organs) versus a model of experimental 
cerebral malaria caused by P. berghei ANKA (which causes pathology in the brain of 
mice).  
9. Identification of antiparasitic domains within PF4. PF4 is comprised of three 
domains: an N-terminal cytokine domain, a central domain responsible for 
tetramerization, and a C-terminal amphipathic helical region with HDP activity (C12). We 
have evidence that C12 retains the ability to kill parasites, at reduced potency, and that 2 
of 4 lysines on the positive face of this peptide are required for activity. Using this 
information we can hypothesize that these properties will also be present in the full 
length protein. We hypothesize that the need for 2 positive charges to maintain facial 
amphipathicity in the α-helical domain of PF4 will also be true in the full-length protein. 
To test this, we could recombinantly express full-length PF4, mutating all lysines 
individually and in combinations of doubles, triples, and a quadruple mutant to determine 
not only if two lysines are necessary for HDP activity, but also if specific lysines are 
important. The resultant proteins will then be tested against P. falciparum in culture, and 
activity of the PF4 mutants will be compared to wild type PF4 to assess for IC50 trend 
and antimalarial activity. 
10. Development of peptidomimetics based on the HDP domain of PF4. In an 
effort to further understand the interaction of PF4 antimalarial activity and generate tools 
for use for in vivo mouse malaria studies, we will synthesize an array of derivatives 
based on the C12 domain of PF4 via standard synthetic routes. The underlying principle 
to the generation of these C12-based tool compounds is to increase their stability and 
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potency in vitro and in vivo while maintaining low host toxicity. Ultimately, this will build 
the knowledge for future efforts to produce a biological therapeutic for malaria.   
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